Health risk assessment of lead exposure to children in Blantyre, Malawi by Utembe, Wells Robert
HEALTH RISK ASSESSMENT OF LEAD EXPOSURE TO 
CHILDREN IN BLANTYRE, MALAWI 
 
Wells Robert Utembe 
 
A thesis submitted to the School of Public Health, Faculty of Health 
Science, University of the Witwatersrand, Johannesburg, in 
fulfilment of the requirement for the degree of Doctor of 
Philosophy 
 
 
Johannesburg, August 2016 
Supervised by 
Professor Mary Gulumian 
Department of Molecular Medicine and Haematology 
 
 
 
 
 
 
 
 
2 
 
Candidate’s declaration 
I, Wells Robert Utembe, declare that this thesis is my own work.  It is being submitted for 
the degree of Doctor of Philosophy in the University of Witwatersrand, Johannesburg.  It 
has not been submitted before for any degree or examination at this or any other 
University. I also declare that the (intellectual) content of the thesis is the product of my 
own work (including the literature review, proposal development and research design, 
sample and data collection, laboratory analysis, data analysis and manuscript preparation), 
except to the extent that assistance was rendered by others in the sample and data 
collection, laboratory analysis and presentation and linguistic expression as acknowledged 
in the thesis. 
  
…15…day of August .2016 
 
 
 
Dedication 
I dedicate this to my wife Linda and my daughters Laura, Amanda and Stacy who have had 
to endure husband’s and dad’s absence for protracted periods.   
 
 
 
 
 
 
3 
 
Publications and presentation arising from the thesis 
Conferences and seminars 
1. Utembe W, Health risk assessment of lead among children in Blantyre City 
Malawi, National Institute for Occupational Health (NIOH) Research Forum, 16 
March 2016 
2. Utembe W, L Alfazema, M Kamndaya, M Gulumian, Levels of blood lead and 
sources of lead exposure among children in Blantyre City, Malawi, 7
th
 Wits Cross- 
Faculty Symposium, 1
st
 March, 2016 
3. Utembe W, L Alfazema and M Gulumian, Health risk assessment of lead among 
children in Blantyre City, Malawi: Evaluation of the IEUBK model, 11
th
 Public 
Health Association of South Africa (PHASA) conference in Durban, South Africa, 
8
th
 - 9
th
 October, 2015 
4. Utembe W, L Alfazema, M Kamndaya, M Gulumian, Prevalence and determinants 
of high blood lead levels among children in Blantyre, Malawi, poster presented at 
the 10
th
 Public Health Association of South Africa (PHASA) conference in 
Polokwane, South Africa, 2
nd
 - 6
th
 September, 2014 
5. Utembe W, L Alfazema, and M Gulumian, Key outstanding  issues in the health 
risk assessment of lead:  Implications for Africa, 6th Conference of the Society of 
Environmental Toxicology and Chemistry (SETAC) Africa, Lusaka Zambia, 2nd - 
3rd   September  2013 
6. Utembe W, Key outstanding issues in the health risk assessment of lead and their 
implications for Africa, Keynote lecture, International Chemistry Conference in 
Africa (ICCA) 2013, University of Pretoria, 8-12 July 2013 
4 
 
Abstract 
Although lead (Pb) is highly toxic, exposure to Pb has not been studied in Malawi.   The 
aims of this study were therefore to: 
1.  Determine the levels of Pb from different sources of exposure such as food, water, 
and soil/house dust to predict the levels of Pb in blood (BPb) using the Integrated 
Exposure Uptake Biokinetic (IEUBK) model.   
2. Measure the levels of BPb and compare to those predicted from the IEUBK model 
as an indication for its applicability in Malawi. 
3. To relate the measured and predicted BPb levels as well as the prevalence of high 
BPb to potential health effects using the WHO and CDC guidelines. 
4. Assess burden of disease using WHO spreadsheets. 
5. Identify additional sources and risk factors for exposure to Pb in children in Malawi 
to assist the policy makers to reduce exposure to lead. 
 
 
In this cross-sectional study 152 children, aged 1-6 years, were recruited.  To determine 
sources of exposure, children’s toys, domestic paints, foods, house dust, playground soil 
and water were collected and analyzed for Pb. A Pb exposure risk assessment 
questionnaire was also administered to identify potential risk factors and a 7-day food 
frequency questionnaire was used to collect information on food consumption. For 
measured BPb levels, venous blood was collected and analysed.  Logistic regression was 
performed in STATA to evaluate the relationship between risk factors and high BPb (BPb 
≥ 5 µg/dl).  
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The comparisons between predicted and measured blood lead showed that the IEUBK 
model may be used provided that the bioavailability values for lead from different sources 
are available as well as the food consumption rates are provided for Malawi.. There was 
also a high prevalence (71.7%) of high BPb that is expected to result in 8.38 cases of mild 
mental retardation per 1000 children aged less than five years.  From the identified risk 
factors, only areas of residence has correlated to prevalence of high BPb in statistically 
significant manner (p = 0.013).   
 
 
It can therefore be concluded that IEUBK model may be used for Malawi, that a significant 
proportion of children in Blantyre are exposed to levels of lead that are detrimental to their 
health and that exposure to lead in Blantyre require urgent intervention measures. 
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1.0 Introduction 
This chapter gives the context of the study, introduces lead as a toxic substance and gives 
the background information on lead exposure in Malawi.  It also explains the focus of the 
paper, the main hypothesis and objectives, and provides a literature review of existing 
research in the area of health risk assessment of lead.  
 
 
1.1  Background  
Although lead poisoning has been investigated as a major public health problem, many 
countries, very few countries in Africa have conducted such investigations.  Malawi is no 
exception, where there has been no exposure assessment to lead particularly with regards 
to children.  This study takes focus on exposure of lead in children in Blantyre City, 
Malawi, and also explores the potential adverse health effects associated with these 
exposures. Blantyre City is located within the larger district of Blantyre, where in this 
document ‘Blantyre’ refers to the city and not to the district. 
 
 
Exposure to lead causes many toxic effects, especially in young children, including 
haematological, gastrointestinal, reproductive, cardiovascular and neurological effects 
(Gerber et al., 1980, Lockitch, 1993).  Many studies have also shown an association 
between blood lead (BPb) and reduction in intelligence quotient (IQ) as well as school 
performance, and violent behavior (Alan S, 2001a, Alan S, 2001b).   
 
 
19 
 
Sources of lead exposure are summarized in Figure 1 below.  In the 20
th
 century, the most 
important source of lead was petrol containing lead (often referred to as ‘leaded petrol’) 
petrol which by 2006 was banned in many countries including Malawi.  The banning of 
leaded petrol was expected to reduce exposure to lead considerably.  However, a large 
 
 
Figure 1:  Sources of lead exposure in children and toxicity (WHO, 2003).  Additional 
sources (colured red) added as per references in the text (Section 1.7) 
 
 
 body of evidence shows that children are exposed to lead from lead-based paint, which is 
distributed through contaminated dust and soil (Clark et al., 2006, Clark et al., 2009, 
Kumar and Pastore, 2007). Lead compounds are used as colour pigments, in addition to 
improve many properties of paint including, the durability, resistance to corrosion and 
drying. Children’s toys can also contain lead from the exterior paint and poly vinyl 
chloride (PVC), where lead is used as a stabilizer (Kumar and Pastore, 2007). Many 
countries, especially developed countries, regulate the concentration of lead in domestic 
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paints and children’s toys (Clark et al., 2006, Clark et al., 2009, Kumar and Pastore, 2007).  
However, Malawi does not have such regulations.    
 
 
It can be seen from Figure 1 that exposure to lead may also occur from some 
environmental media such as air, soil, water and food (Lanphear et al., 1998, Lanphear and 
Roghmann, 1997).  The contributions of lead from various sources and pathways differ 
from country to country or regions within one country.   
 
 
It can also be seen in Figure 1 that exposure to lead may either be assessed through the 
measurement of its concentration in biological specimens, usually blood, or in various 
environmental media (food, water, soil, air and dust).  A number of countries in Africa 
have therefore measured lead in blood and/or lead in various sources (Mathee et al., 2002, 
Mbongwe et al., 2005, Nriagu et al., 1997b).  Using similar measures, the present study has 
assessed exposure to lead in blood and also in different media, with the aim of assessing 
the levels of exposure to lead in children in Blantyre and the associated risk of suffering 
from adverse health effects.  Furthermore, the study aim is to identify external (risk) 
factors that may cause some children to be at a higher risk of exposure.  It is hoped that by 
establishing the levels of exposure from different sources and the associated adverse 
effects, this research may influence public health policy on lead in Malawi.  The study uses 
approaches derived from epidemiology and toxicological (health) risk assessment.    
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1.2 Problem statement 
Although the acute and chronic toxicities of lead have already been recognized 
internationally, the government of Malawi only regulates the use of leaded petrol, with no 
other regulation.  Exposure to lead, particularly in children, has also not as yet been studied 
in Malawi.   
 
 
1.3 Overall hypothesis of the study 
Children in Blantyre are exposed to lead levels that may be detrimental to their health. 
 
 
1.4  Significance of study 
It is hoped that this study, the first of its kind to be conducted in Malawi, will assess the 
possibility of exposure to lead in children from different sources. In doing so, this research 
will guide policy makers regarding the sources of lead and their management thereof in 
Malawi. 
 
 
1.5 General aim  
To assess the exposure to lead and potential adverse health effects among children in 
Blantyre. 
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1.5.1 Specific aims 
1. Determine the levels of lead from different sources of exposure such as food, water, 
and soil/house dust to predict the levels of BPb using the Integrated Exposure 
Uptake Biokinetic (IEUBK) model.   
2. Measure the levels of BPb and compare to those predicted from the IEUBK model 
as an indication for its applicability in Malawi. 
3. To relate the measured and predicted BPb levels as well as the prevalence of high 
BPb to potential health effects using the World Health Organization (WHO) and 
United States  Centers for Disease Control and Prevention (CDC) guidelines  
4. Assess burden of disease using WHO spreadsheets. 
5. Identify additional sources and risk factors for exposure to Pb in children in Malawi 
to assist the policy makers to reduce exposure to lead. 
 
 
1.6 Literature review 
1.6.1 Toxicokinetics of lead 
Toxicokinetics of lead studies its absorption, distribution, metabolism and elimination in 
the body.  Lead may enter the human body through ingestion, inhalation or dermal 
exposure to be absorbed into and transported by the bloodstream, where over 95% of lead 
is found in red blood cells (RBC), and about 1% in the plasma and serum (Dorman, 2012).  
Although only a small proportion of lead exist in the plasma, it is considered significant 
because it acts as a means of distribution to target organs such as kidney, lungs, brain, 
spleen, teeth, and bones (Papanikolaou et al., 2005).  As lead can readily substitute calcium 
(Ca
2+
), the skeletal system serves as a long-term storage of lead (75% in children and 
between 90 and 95% in adults) (Barry and Mossman, 1970). This stored lead can be 
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mobilized from bone to blood and other tissues, especially during periods of altered 
mineral metabolism such as during pregnancy and lactation (Gulson et al., 1998).   
 
 
Since inorganic lead (Pb
2+
), the most predominant form of lead in the environment, is not 
metabolized, the rate of excretion of lead is low, mostly through urine. Lead may also be 
excreted with bile through the gastrointestinal tract. An assessment of the rate of decline of 
BPb indicated that periods of 24.0, 20.9, 14.3, and 9.2 months are required for BPb in the 
ranges of 25–29, 20–24, 15–19, and 10–14 µg/dL to decline to less than 10 µg/dL (Roberts 
et al., 2001).  On the other hand, lead in soft tissues has a mean life-time of 40 days 
whereas lead in bones has a lifetime of close to 30 years (Rabinowitz et al., 1976).  The use 
of chelating agents can enhance lead excretion in urine.   This is the basis of lead chelation 
therapy (Lowry, 2010).  
 
 
The toxicokinetics of lead is affected by a number of metabolic and nutritional factors 
(Dorman, 2012, NRC, 1993).  For example, strong negative correlations have been 
observed between calcium (Mahaffey et al., 1986, Blake and Mann, 1983) and iron 
(Wright et al., 2003, Hammad et al., 1996, Kwong et al., 2004) intake and BPb.   These 
two elements affect absorption of lead probably because they share common transport 
mechanisms in the gut (Mykka and Wasserman, 1981, Abbaspour et al., 2014).  Since 
calcium and iron affect absorption of lead, they are sometimes referred to as ‘effect 
modifiers’ of lead.   
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1.6.2 Mechanism of toxicity and health effects of lead 
For centuries, lead was known as a neurotoxin that only affected workers in lead industries 
until in the 1960s when its exposure was identified in children (Marjorie, 1985).  Follow-
up studies on children with lead poisoning revealed neuropsychological development 
deficits and violent behaviour (Needleman et al., 2002, Tong et al., 2000).  
 
 
Lead is a chronic poison with relatively high oral LD50 values, 2,000 mg/kg b.w. (EFSA, 
2010) and 1200 mg/kg b.w (IPCS, 1995), reported in the literature.  However, chronic 
exposure lead can result in  many toxic effects in adults and children (Lockitch, 1993). 
Lead causes its toxic effects through its affinity for proteins and enzymes (Goering, 1992), 
particularly proteins that naturally bind Ca
2+
 and zinc (Zn
2+
) (Godwin, 2001).  This 
interaction is reported “to consist of reversible binding of lead to sulfhydryl groups or to 
other protein sites capable of binding the bivalent cations”, where the binding induces 
conformational changes in the protein structure, leading to changes in their functioning 
(Landrigan et al., 2000).  
 
 
Due to the physico-chemical similarities between Pb
2+
 and Ca
2+
, lead mimics calcium in a 
number of processes.  Ca
2+ 
ions play a ubiquitous role as intracellular messengers for 
transducing electrical and hormonal signals. The concentration of Ca
2+
 in cell cytoplasm is 
normally maintained between 50 and 150 nM by the Ca
2+
 homeostasis system. Electrical 
signal or hormonal signals are transduced by increasing the concentration of Ca
2+
 in one or 
more parts of the cell (NRC, 1993). Lead is reported to interfere with this process in many 
cells and nerve terminals, and thereby “affecting synaptic transmission, neuronal 
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differentiation, permeability of brain capillaries, neuroendocrine function, protein 
phosphorylation, catecholamine synthesis and others” (Godwin, 2001). The impacts of 
Ca
2+
 on cell signals result in neurotoxicity and cardiovascular impairment (Landrigan et 
al., 2000).  
 
 
The physico-chemical similarities between Pb
2+
 and Ca
2+
 also result in storage of lead in 
bones.  This compromises bone cell function, which may result in a number of bone 
ailments, including osteoporosis (a reduction in bone mass that may lead to bone fracture) 
(Campbell and Auinger, 2007), delayed fracture healing and fibrous nonunions (fractures 
that do not heal) (Carmouche et al., 2005), and dental carries (Moss et al., 1999, Gemmel 
et al., 2002).     
 
 
Lead has also been shown to induce apoptosis, programmed cell death, in a number of 
types of cells, through depolarization of rod cell mitochondria which result in cytochrome 
c release, caspase activation and apoptosis (He et al., 2000, Xu et al., 2006).  Lead is 
particularly toxic to immature astrocytes and interferes with the formation of myelin, and 
thus disrupts the formation of the blood-brain barrier.  The disruption of the formation of 
blood-brain barrier during foetal development and early infancy results in most of 
neurotoxicity of lead in children since the disruption of the central nervous system (CNS) 
allows molecular proteins like albumin to enter tissues of the CNS which can result in 
edema, increased intracranial pressure, and encephalopathy (Patrick, 2006). Lead was also 
shown to inhibit neurogenesis and to alter the pattern of differentiation of newly born cells 
in the dentate gyrus of rat hippocampus (Jaako-Movits et al., 2005) and it was shown to 
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cause alterations in neurotransmitter receptors, mitochondria, second messengers, 
cerebrovascular endothelial cells, astroglia and oligodendroglia (Sanders et al., 2009). Lead 
also affects the motor axons in the peripheral nervous system, which causes segmental 
demyelination and axonal degeneration in these fibres (Landrigan and Todd, 1994, 
Landrigan, 1989),  In summary, effects of lead on the brain and CNS can result into a 
number of neurological disorders, including brain damage, nerve damage, mental 
retardation, behavioral problems, problems with vision and hearing,  and probably 
neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and 
schizophrenia (Sanders et al., 2009, Bushnell et al., 1977, Osman et al., 1999). 
 
 
As stated earlier, lead also causes its toxic effects through its affinity for proteins and 
enzymes, especially proteins that naturally bind Ca
2+
 and zinc (Zn
2+
). Among the proteins 
that bind Zn
2+
 is the zinc enzyme δ-aminolevulinic acid dehydratase (ALAD), also known 
as porphobilinogen synthase. ALAD catalyzes the second reaction in the haem biosynthetic 
pathway (Figure 2), a process that has been shown to “begin with succinyl coenzyme A 
(CoA) and glycine and ends with the insertion of iron (Fe
2+
) into a molecule of 
protoporphyrin (by the enzyme ferrochelatase)” (Onalaja and Claudio, 2000).  In the first 
step, the enzyme aminolevulinic acid (ALA) synthase catalyses the formation of ALA 
from glycine and succinyl coenzyme A (CoA).  In the second step, ALAD catalyzes the 
formation of porphobilinogen from two molecules of ALA. ALAD has a high affinity for 
lead, as lead binds to the enzyme's SH group, a group that normally binds zinc.  The 
inhibition of ALAD activity results in the accumulation of ALA in blood and urine 
(Onalaja and Claudio, 2000).  The disruption by lead of the biosynthesis of haem process 
(Figure 2) may also result in anaemia. 
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Figure 2:  Schematic presentation of the enzymatic steps involved in heme synthesis 
pathway (USEPA, 1986) 
 
 
Lead has also been shown to inhibit the activities of antioxidant enzymes, including 
glutathione peroxidase, catalase and superoxide dismutase, and induce oxidative stress that 
may lead to DNA damage, lipid peroxidation and protein oxidation (Bolin et al., 2006, Xu 
et al., 2008).  Generation of reactive oxygen species (ROS) and depletion of antioxidant 
reserves have been linked with many lead induced ailments.  Unlike redox-active metals 
that produce reactive oxidative species through Fenton–like mechanisms, redox-inactive 
metals such as lead generate ROS through depletion of major sulfhydryl reserves.  Lead 
generates ROS through oxidation of ALAD, a sulfhydryl containing enzyme as shown in 
the following equations below, where enolization of ALA is followed by aerobic oxidation 
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that induces the generation of superoxide (O2
.-
) and peroxide (O2
2-
) radicals (Ercal et al., 
2001): 
 
    (            )      (           ) 
    (           )          
              
            
                             
  
   
                   
       
                    
 
 
Overall, lead affect enzymes, disrupts cellular metabolism of calcium (and thus affecting 
conduction in nerves), and causes apoptosis and oxidative stress, processes that may result 
in neurotoxic, nephrotoxic and cardiovascular effects, and many other effects” (Gerber et 
al., 1980, Goyer, 1990, Goyer, 1993, Kaufman, 2001, Landrigan et al., 2000, Needleman, 
2004, Patrick, 2006, Schwartz, 1994). Symptoms for acute lead poisoning are numerous 
and are not unique to lead poisoning, including headaches, vomiting, dizziness, stomach 
cramps, most of which appear only at high levels of exposure and long periods after 
exposure (Needleman, 2004).  The health effects are discussed in detail in the ensuing 
sections. 
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1.6.2.1  Health effects of lead 
1.6.2.1.1 Neurobehavioral effects of lead 
1.6.2.1.1.1 Neurobehavioral effects of lead in children  
The interruption of the processes of neural and brain development in children by lead can 
result in a permanently altered brain function.  Consequently, lead has been linked to a 
number of neurobehavioral disorders in children which have often manifested in reduction 
in IQ, violent behavior, crime and pregnancies outside marriage in many countries 
including, Britain, Canada, France, Australia, Finland, Italy, West Germany, and New 
Zealand (Needleman et al., 2002, Needleman et al., 1996, Nevin, 2000, Nevin, 2007).  
However, it is important to note that since neurobehavioural effects of lead in children do 
not have easily detectable symptoms, and since they have prolonged latency periods, they 
have offered special challenges to analysts (Weiss, 1988). Furthermore, these effects are 
affected by many other factors including but not limited to, parenting skills, parenting 
styles of child rearing, parental time spent with the child, the skills and styles of key 
caretakers other than the parents, genetic factors, levels of education of parents and socio-
economic status.  These factors are often not controlled for in many studies (Kaufman, 
2001). 
 
 
Nevertheless, despite of the challenges and short comings in many studies, there is enough 
evidence to show a link between lead exposure and IQ reduction.   For example, a 
correlation between lead exposure and IQ has been shown in a meta-analysis  in which an 
increase in BPb from 10 µg/dL to 20 µg/dL is associated with a mean reduction of 2.6 IQ 
(Schwartz, 1994).  
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There is also enough evidence in both animal and human studies to establish a link 
between lead exposure and attention-deficit/hyperactivity disorder (ADHD) in children.  
ADHD is a neurobehavioral disorder that manifests through inattentiveness, hyperactivity, 
and impulsiveness (Sagvolden et al., 2005).  ADHD is subdivided into three main 
diagnostic subtypes: predominantly inattentive, predominantly hyperactive/impulsive 
subtype, and the combined subtype. Predominantly inattentive children appear dreamy and 
inert, with poor focus to attention and less accuracy in information processing. 
Predominantly hyperactive/impulsive children have inattention specifically related to 
distractibility and reduced persistence (Taylor, 1998, Sagvolden et al., 2005). They are 
shown to “have memory retrieval problems, exhibit aggressive, oppositional behavior 
leading to adolescent delinquency and substance abuse, and suffer peer rejection” 
(Sagvolden et al., 2005). 
 
 
Associations between levels of BPb with ADHD have been shown in many countries.  In 
the United States of America (USA), children with BPb ≤ 5 µg/dL were about 3 times 
more likely to have ADHD than children with BPb below 5 µg/dL, with 290,000 of the 1.8 
million cases of ADHD among U.S. children of attributed to lead exposure (Braun et al., 
2006).  A dose-dependent association between BPb and ADHD was also established in 
Korea, where ADHD could be attributed to lead even at very low BPb (1.5 µg/dL) (Ha et 
al., 2009).  Associations between BPb and BPb have also been established in China, where 
children with BPb ≥ 10 μg/dL were 6 times more likely to develop ADHD compared to 
children with BPb ≤ 5 μg/dL, and children with BPb in the range 5–10 μg/dL were 5 times 
more likely to develop ADHD compared to children with BPb ≤ 5 μg/dL (Wang et al., 
2008).  Lead induced ADHD (and IQ reduction) manifest as a reduction in school 
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performance especially at BPb levels above 10 µg/dL as reported in many studies 
(Chandramouli et al., 2009, Miranda et al., 2009, Miranda et al., 2007).   
 
 
1.6.2.1.1.2   Neurobehavioural effects in adults 
Similar to children, neurotoxic effects have also been observed in adults, although in adults 
they appear to be initiated at BPb levels of about 18 µg/dL, whereas in children they are 
observed at BPb levels below 10 µg/dL (Murata et al., 2009). The main neurotoxic effect 
in adults is the decline in cognitive functions, which has been reported following both 
environmental and occupational exposures (Schwartz et al., 2005, Shih et al., 2006, Dorsey 
et al., 2006).  Neurological effects can also be detected in adults 20 years after childhood 
environmental exposure (Stokes et al., 1998).   
 
 
Effects of lead on the CNS also result on adverse effects on sensory faculties such as eye 
sight and hearing.  In this regard, lead  has been shown to cause impairment of scotopic 
vision (night blindness) in monkeys (Bushnell et al., 1977, Lilienthal et al., 1994). 
Similarly in humans, an association was established between chronic lead exposure and the 
age-related risk of cataract in men (Schaumberg et al., 2004).  In addition, occupational 
and environmental lead exposure also causes impairment in hearing (Forst et al., 1997, 
Choi et al., 2012).   
 
 
Since it is now recognized that parameters of fetal, infant, and childhood growth may be 
predictors of disease in later life, there have been speculations on the possible role of lead 
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in neurodegenerative disease such as Alzheimer’s disease and Parkinson disease (Prince, 
1998, Landrigan et al., 2005).   Indeed,  it has been reported that exposure to Pb early life 
can reprogram gene expressions that can result in both upregulation and down-regulation 
of genes that may contribute to neurodegeneration in old age, leading to Alzheimer’s 
disease (Bihaqi et al., 2011, Wu et al., 2008). However, a meta-analysis on retrospective 
occupational exposures to lead found not association between lead and the disease (Graves 
et al., 1991).  These conflicting results are expected as studies on early exposures to lead 
and the onset of Alzheimer’s disease are beset by long latency periods and lack of 
validated circulating epigenetics biomarkers and retrospective biomarkers of Pb exposure 
(Bakulski et al., 2012).   
 
 
Associations have also been found exposure to lead and the development of Parkinson’s 
disease, where more than 20 years of co-exposures to lead and copper and lead and iron 
were found to be risk factors for Parkinson’s disease, with odd ratios 5.24  and 2.83 
respectively (Gorell et al., 1997).  Divalent metals such as Pb
2+
 accelerates  the  rate of 
formationof α-synuclein fibril, which is involved in Parkinson's disease (Uversky et al., 
2001).  
 
 
1.6.2.1.2  Reproductive and developmental effects of lead 
1.6.2.1.2.1  Reproductive and developmental effects of lead in children 
Reproductive and developmental effects of lead administered ad libitum to rats in utero, 
pre-pubertally, or post-pubertally included a decrease in weights of sex organs and 
suppression of serum testosterone levels in males, and delayed vaginal opening and 
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disrupted estrus cycling in females.  The effects on reproductive physiology and growth 
appeared to involve actions at multiple sites on the hypothalamic–pituitary–gonadal axis, 
probably resulting from disruption of calcium-dependent secondary messenger systems 
(Ronis et al., 1996).  Indeed, epidemiological studies have shown environmental exposure 
to lead may delay growth and pubertal development in girls (Selevan et al., 2003, Naicker 
et al., 2010a). 
 
 
1.6.2.1.2.2 Reproductive and developmental effects of lead in adults 
In male mice lead was shown to inhibit spermatogenesis and sperm development (Wang et 
al., 2013).  Similarly in men, lead can impair the production of sperms and reduce 
concentrations of androgens, and consequently “decreased sperm count, volume, and 
density, impaired sperm motility and morphology in male workers” have been reported 
among workers exposed to lead at BPb levels higher than 40 µg/dl (Landrigan et al., 2000).   
Reproductive effects of lead have also been observed among the general population at 
average BPb concentrations of about 5 µg/dl (Telišman et al., 2007). 
 
 
Lead also significantly suppressed circulating levels of luteinizing hormone (LH), follicle 
stimulating hormone, estradiol in monkeys, without inducing overt signs of menstrual 
irregularity (Foster, 1992).  Similarly in women, lead can cause spontaneous abortions and 
low birth weight in infants.  For example, odds ratios of spontaneous abortions of 2.3, 5.4, 
and 12.2, for BPb levels of 5-9, 10-14 and ≥ 15 ug/dL, respectively, in comparison to < 5 
ug/dL, have been reported in Mexico (Borja-Aburto et al., 1999).  Increased frequency of 
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spontaneous abortions and decreased birth weights in children have also been reported in 
Sweden (Nordstrom, 1979).  
 
 
1.6.2.1.3 Effects of lead on the immune system 
Lead affects the immune system, where it suppresses the T helper (Th1)-dependent 
delayed type hypersensitivity (DTH) response, increases production of immunoglobulin E 
(IgE), and increases production of the proinflammatory cytokines tumor necrosis factor 
(TNF) α and IL-6 (Dietert and Piepenbrink, 2006, Dietert et al., 2004).   
 
 
1.6.2.1.4  Lead and anemia  
Lead interferes with heme synthesis and production of RBC, where reduction of RBC 
production has been observed at concentrations above 7.0 µg/dl (Iavicoli et al., 2003).  In 
addition, lead shortens the life spans of RBC (Hernberg et al., 1967). For these reasons 
anaemia is often observed with Pb poisoning.  A strong non-linear dose-response 
relationship between BPb level and hematocrit was observed in a cross-sectional study 
involving children (Schwartz et al., 1990).  In India, children with BPb levels above 10 
µg/dl were 1.3 times as likely to have moderate anemia as children with BPb levels below 
10 µg/dl.  Furthermore, children with BPb levels above 10 µg/dl were at least 1.7 times 
more likely to develop severe anaemia than children with BPb below 10 µg/dl (Jain et al., 
2005).   
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1.6.2.1.5 Lead and renal effects 
1.6.2.1.5.1 Lead and renal effects in children 
Nephrotoxic effects can result from both acute and chronic exposure to lead. Acute lead 
nephrotoxic effects include a deficit of tubular transport mechanisms and degenerative 
changes in the tubular epithelium, manifested in children by glycosuria and aminoaciduria 
and changes in specific ion transport. These changes appear to result from effect of lead on 
mitochondrial respiration and phosphorylation (Goyer, 1989). On the other hand, chronic 
lead nephrotoxic effects include renal dysfunction, characterized by glomerular and tubule-
interstitial changes, and culminating in chronic renal failure, hypertension and 
hyperuricemia (Rastogi, 2008). While acute nephrotoxic effects are reversible upon 
reduction of lead exposure or treatment with chelating agent, chronic nephrotoxic effects 
are irreversible (Goyer, 1989).   
 
 
Nephrotoxic effects have been associated with lead exposure in children in some 
epidemiological studies.  For example, environmental exposure to lead in the vicinity of a 
lead smelter caused slight effects on the proximal tubule function in children in Prague 
(Bernard et al., 1995).  The pattern of nephrotoxic effects in children appear to be similar 
to that observed in adults, although they occur at lower BPb levels than in adults (Fels et 
al., 1998). 
 
 
1.6.2.1.5.2 Lead and renal effects in adults 
Lead-induced nephrotoxic effects have also been detected among workers in many 
countries.  In Singapore, decreased glomerular function was observed among lead-exposed 
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workers (Chia et al., 1995). In the USA, a significant decrement in kidney function was 
detected in lead smelter workers, and in Taiwan BPb and tibia lead were significantly 
associated with changes in renal function among lead workers (Weaver et al., 2009). 
 
 
Studies have also indicated nephrotoxic effects from environmental exposure. For 
example, in Taiwan, longitudinal studies established a correlation between BPb and 
progressive renal insufficiency (Lin et al., 2001, Yu et al., 2004).  Similarly, in the USA, 
an association was obtained between BPb and chronic kidney disease (Muntner et al., 
2003), while in Scotland, a highly significant correlation was established between lead BPb 
and renal insufficiency (Campbell et al., 1977). 
 
 
1.6.2.1.6  Carcinogenic and genotoxic effects of lead 
1.6.2.1.6.1  Carcinogenic and genotoxic effects of lead in children 
Substitution of Zn
2+
 and Ca
2+
 by lead in enzymes that are involved in deoxyribonucleic 
acid (DNA) processing and repair can inhibit DNA repair. Lead may also produce reactive 
oxygen species which can cause oxidative damage to DNA (Silbergeld et al., 2000).  The 
inhibition of DNA repair or oxidative damage to DNA may result in genotoxic effects. 
Therefore, lead is likely to be mutagenic or it is a mutagen (Ariza and Williams, 1996, 
Zelikoff et al., 1988).   
 
 
The direct damage of DNA or inhibition of DNA synthesis or repair may also cause lead to 
be carcinogenic. Indeed, lead has been reported to cause kidney and brain tumors in rats 
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and mice (Mulware, 2013).  However, “because of the limited and inadequate evidence in 
humans and sufficient evidence in experimental animals”, the International Agency for 
Research on Cancer (IARC) classifies inorganic lead compounds as probably carcinogenic 
to humans (Group 2A) (IARC, 2004).  Indeed, DNA damage has been detected in children 
exposed to lead around a mining site (Yáñez et al., 2003), and lead exposure was found to 
cause an increase in micronuclei in children (Kapka et al., 2007), which is an indication of 
DNA damage. This notwithstanding, there appears to be no literature on the prevalence or 
incidence of cancer resulting from lead exposure in children. 
 
 
1.6.2.1.6.2  Carcinogenic and genotoxic effects of lead in adults 
The direct damage of DNA or inhibition of DNA synthesis or repair by lead may also 
result in cancer in adults. Indeed, lead has been linked to stomach and lung cancers in 
workers (Fu and Boffetta, 1995), brain cancer in workers (Cocco et al., 1998)  and  breast 
cancer among the general population (Alatise and Schrauzer, 2010).   
 
 
1.6.2.1.7 Cardiovascular effects of lead 
1.6.2.1.7.1 Cardiovascular effects of lead in children 
Exposure to lead has been shown to be “associated with blood pressure, hypertension and 
increased incidence of cardiovascular complications such as coronary heart disease, stroke 
and peripheral arterial disease, left ventricular hypertrophy and alterations in cardiac 
rhythm” (Pirkle et al., 1985, Navas-Acien et al., 2007, Park et al., 2006). The mechanism 
for  cardiovascular dysfunctions is reported to occur through “impairing nitric oxide 
signaling, augmentation of adrenergic activity, increasing endothelin production, alteration 
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of the renin-angiotensin system, raising of vasoconstrictor prostaglandins, lowering of 
vasodilator prostaglandins, disturbance in vascular smooth muscle Ca
2+
 signaling, 
reduction in endothelium-dependent vasorelaxation, and modification of the vascular 
response to vasoactive agonists” (Vaziri, 2008). An association between prenatal lead 
exposure and blood pressure has been established in children (Zhang et al., 2012). 
 
 
1.6.2.1.7.2 Cardiovascular effects of lead in adults 
In contrast to children where there are only very few studies linking lead exposure and 
cardiovascular effects, there are a number of studies that indicate the link between lead 
exposure and cardiovascular effects in adults both in the general population (Hu et al., 
1996) and among workers (De Kort et al., 1987).  These effects have also been observed in 
animal studies (Nowack et al., 1993, Staessen et al., 1994).  On the other hand, there are 
studies also which could not establish an association between lead exposure and 
cardiovascular effects in the general population (Staessen et al., 1996) and among workers 
(Parkinson et al., 1987, Kirkby and Gyntelberg, 1985, Maheswaran et al., 1993).  Because 
of these contradictions, a systematic review on lead and cardiovascular effects concluded 
that the evidence for a causal relationship of lead exposure with clinical cardiovascular 
outcomes was only suggestive but not sufficient (Navas-Acien et al., 2007).  
 
 
1.7 Sources of lead  
Children are exposed to lead from a number of sources, including food (47%), dust and 
soil (45%), water (6%) and air (1%) (Prüss-Üstün et al., 2006).  Concentrations of lead in 
tap water have been shown to be associated and BPb in many countries (Fertmann et al., 
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2004, Edwards et al., 2009).  As most sources of water have naturally very low lead levels, 
drinking water from the source is usually free of lead. Use of lead for soldering pipes and 
plumbing has in the past been a major source of high lead levels in water. Therefore, water 
may be contaminated as it is distributed from the water treatment plant through lead water 
pipes and across lead-soldered joints into homes (Renner, 2009). As soft, acidic water has 
the greatest tendency to dissolve lead (plumbosolvency), plumbosolvency is decreased 
when the pH and water hardness are increased through the addition of lime (Fergusson, 
1986). Indeed, when lead pipes were still in use it was shown in England that towns that 
had soft water supplies had the highest water lead concentrations and consequently the 
highest mean BPb concentrations (Pocock et al., 1983).  Lead pipes are no longer used for 
water distribution throughout the world.   
 
 
Food can be a significant contributor to BPb, contributing as much as 72% of the total 
daily lead intake (Wilheim et al., 2003). Lead in food can come from environmental 
contamination of crops through atmospheric deposition, soil or water. Since there are 
spatial variations in environmental contamination of lead, there can be variations in lead 
concentrations in foods from different regions of the same country (Cuadrado et al., 2000). 
The variations can also result from the methodological challenges in sampling and dietary 
exposure assessment (Elwood, 1986). 
 
 
Lead contamination of food can also result from use of contaminated utensils/apparatus for 
food preparation or storage.  As an example, lead-glazed ceramics are an important source 
of lead contamination in some countries (De Mejía and Craigmill, 1996), where a 
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correlation could be found between use of lead-glazed ceramics and BPb among women in 
Mexico (Avila et al., 1991).  In addition, food and drink cans soldered with lead-based 
solder can also be an important source of lead (Sherlock, 1987). 
 
 
Lead exposure can also result from paint since lead pigments are often used in domestic 
and industrial paints.  Paint is essentially composed of a binder, pigment and solvent. 
Binders are usually polymeric substances that are added to the paint to hold the pigment to 
the surface of the wall. Pigments are used primarily to give the paint its colour and finish, 
as well as protecting the surface underneath from corrosion and weathering (Clark, 2000). 
Common lead-based pigments include white lead (2PbCO3.Pb(OH)2)), vivid yellow lead 
chromate (PbCrO4), basic lead chromate (PbCrO4.Pb(OH)2), lead molybdate (PbMoO4), 
lead carbonate (PbCO3), red lead (Pb3O4), leaded zinc oxide (white lead + ZnO), basic lead 
sulphate (2PbSO4.PbO), litharge (PbO) and basic lead silicate (PbO.SiO2) (Sturges and 
Harrison, 1985). Lead pigments are often preferred  to other paint pigments because of 
their durability and bright colours (Filippelli and Laidlaw, 2010, RSC, 2007).   
 
 
Lead compounds may also be added to enamel (oil-based) paints to act as driers 
(sometimes called drying agents or catalysts).  The driers serve as catalysts that speed up 
the polymerization, and thus make paints dry faster and more evenly (UNEP, 2013). Lead 
compounds that are commonly used as driers include lead octoate, lead acetate and lead 
naphthenate. Lead compounds are also sometimes added to paints used on metal surfaces 
to inhibit rust or corrosion, where the most common of these is lead tetroxide (UNEP, 
2013). Children can be exposed to lead when lead-based paints are applied in their 
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environments, where they can be exposed when they play with walls, through dust when 
they play on the floor and through direct eating of paint chips in a habit known as pica.  In 
this regard, paint flakes make significant contributions to lead in house dust and street dust 
(Gulson et al., 1995, Gulson et al., 1997, Sturges and Harrison, 1985).  Consequently, 
house dust has been found to be a significant source of BPb (de Freitas et al., 2007, Dixon 
et al., 2008, Kumar and Scott Clark, 2009, Lanphear et al., 1998, Lanphear and Roghmann, 
1997).  
 
 
Lead-based paint is also often applied to children’s toys through which children can be 
exposed to lead via mouthing behavior.  Children’s toys made of PVC can also contain 
lead through the use of lead as a stabilizer in PVC.  For these reasons, studies on lead in 
toys in many countries have shown lead levels above permissible limits (Greenway and 
Gerstenberger, 2010, Kumar and Pastore, 2007, Omolaoye et al., 2010), which is currently 
100 mg/kg in the USA (CPSC, 2008).  Heavy metals, including lead, are found to be 
bioaccessible from PVC toys (Guney and Zagury, 2014).    
 
 
Lead can also be found in air.  Sources of lead emissions include traffic (Monna et al., 
2006), industries and waste combustion (Sun et al., 2006), thermal power stations (Liang et 
al., 2010), lead smelters (Roels et al., 1980, Kalač and Stašková, 1991), lead-zinc smelters 
(Gulson et al., 2004), copper smelters (Carrizales et al., 2006) and mining (Davies and 
White, 1981, Zheng et al., 2013). Atmospheric concentrations of lead were high in areas 
where there was use of leaded petrol or industries that dealt with lead, especially mining.  
However, the most important source of lead in air appears to have been leaded petrol, 
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which is now banned in almost all countries of the world, leading to a significant reduction 
in atmospheric lead.  Internationally, after the introduction of regulations on  lead in 
gasoline, concentrations of lead air have been reported to be reduced to about  0.2 µg/m
3
 
(Thomas et al., 1999). In the USA BPb levels were observed to decline as atmospheric lead 
declined (Hayes, 1994).   
 
 
There are also many numerous sources of lead that can be termed as ‘miscellaneous 
sources’ because they are not well documented or characterized.  These include crayons 
(CUS, 2004), finger paints (Rastogi, 1992), jewels (CDC, 2015), cosmetics (Bocca et al., 
2014) and fishing sinkers (Mathee et al., 2013).  Occupational sources of lead are not 
within the scope of the present study except in the cases where parents may bring lead 
from work through clothes and equipment.  The most important sources of lead exposure 
to children at home are summarized in Figure 3 below. 
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Figure 3:  Sources of lead at home (adopted from http://www.faqs.org/health/Sick-
V3/Lead-Poisoning-Prevention.html) 
 
 
1.8 Factors that affect levels of exposure to lead among children 
In addition to the previously described sources of lead, there are factors that have been 
found to affect the levels of exposures among children from these identified sources.  
These factors are often referred to as ‘risk factors’, defined as factors that increase the 
likelihood of developing a disease, a condition or injury (WHO, 2016).  They are also 
sometimes termed as  ‘determinants’ (Menezes-Filho et al., 2011) or ‘predictors’ 
(Friedman et al., 2005) of lead exposure.   They are usually demographic, socio-economic, 
nutritional and genetic factors that are often different among countries and even within 
regions of the same country.   These factors are the reasons why within the same 
environment some children may have higher BPb than others.  An understanding of these 
factors is important for rational and effective design of control measures (Burstyn and 
Teschke, 1999).   
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Some risk factors may easily be linked to the various sources of lead, including living near 
an industrial site (Menezes-Filho et al., 2011), use of glazed kitchenware (Isidra et al., 
2003), distance of house from a smelter, proximity of a house to busy streets, applying of 
surma to eyes, having a father who works with lead (Rahbar et al., 2002), mouthing 
behaviours, or residing in mining towns (Malcoe et al., 2002).  On the other hand risk 
factors such as age, levels of income and education (socio-economic status), and gender 
(CDC, 2001, Olaiz and Fortoul, 1996)  and having a teenage mother at birth (Naicker et al., 
2010b) may be linked to some habits that directly or indirectly increase the risk of 
exposure. Genetic and nutritional factors affect the toxicokinetics of lead in the body, and 
therefore can be viewed as effect modifiers, factors that can affect the magnitude of 
the effect of exposure. In this regard, zinc deficiency increases lead absorption, while 
calcium and iron deficiency increase the retention of lead and thus increases the severity of 
effects (Mason et al., 2014).  The nutritional factors partly accounts for relationship 
between socio-economic status and lead exposure.  The role of nutritional factors on lead 
toxicity has been discussed in Section 1.6.1, while the role of genetic factors is discussed in 
more detail in Sections 1.10.3.1.3. 
 
 
Risk factors that are associated with high exposure to lead are often utilized in lead 
exposure risk assessment questionnaires in many developed countries, particularly by the 
CDC.  Lead exposure risk assessment questionnaires serve as initial screening tools for 
identifying subjects, especially children, who may be at a high risk to exposure to lead.  In 
this type of assessment children that are found to be at risk are subjected to blood test for 
lead.  In this regard, an evaluation of one such questionnaire in Illinois indicated that the 
questionnaire would identify most children with high BPb (Binns et al., 1999).   
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1.9 Studies on exposure to lead in Sub-Saharan Africa 
In Sub-Saharan Africa there have been relatively few studies on exposure to lead in blood 
and/or sources of lead including food, air, water, soil, toys, paint, crayons, medicines 
(herbal and western) and cosmetics.  Most studies have been conducted in South Africa 
and Nigeria, where most of these studies were on the identification of the sources of lead 
and levels of exposure, often with no accompanying risk assessment resulting from the 
exposures. 
 
 
In South Africa, prior to regulations on lead in petrol in 1996, a 13% of urban children of 
mixed race had BPb levels above 25 µg/dL (von Schirnding et al., 1991).   These levels of 
BPb in urban areas ware also confirmed to be greater than 25 µg/dL, compared to children 
in rural areas, where only 2% of the children had BPb levels greater than 10 µg/dl (Nriagu 
et al., 1996, Nriagu et al., 1997a).  Subsequent to the introduction of regulations on lead in 
petrol in 1996 BPb, BPb levels were reported to be within the range of 1.0 and 24.5 µg/dL, 
with 10% of children having BPb levels ≥ 10 µg/dL (Mathee et al., 2006).  The impact of 
the introduction of regulations on lead in petrol was confirmed in another study where the 
average BPb was 4.9 μg/dL, with 49% of the population having BPb  ≥  5.0 μg/dL and 
only 1% > 10.0 μg/dL (Naicker et al., 2010a). 
 
 
 In Nigeria, prior to the banning of leaded petrol the mean BPb in children aged 1-6 years 
was found to be 10.6 µg/dL (Nriagu et al., 1997b). There appear to be no other studies on 
BPb in Nigeria that may indicate the impact of introduction of regulations on lead.  
However, as a confirmation of the importance of other sources of lead, investigations into 
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the fatal lead poisoning outbreaks in Nigeria showed that 97% of children had BPb ≥  45 
μg/dL, resulting from gold ore processing (Dooyema et al., 2012, Lo et al., 2012). 
 
 
Studies on lead in blood were also conducted in other countries, such as Botswana, where 
at the time regulations on leaded petrol were introduced, 31% of children were shown to 
have BPb  ≥ 10 µg/dL (Mbongwe et al., 2005), and in Uganda,  where the mean BPb after 
the introduction of regulations on leaded petrol was 7.15 µg/dL, with 20.5% of the children 
having BPb above10 µg/dL (Graber et al., 2010).  In addition to studying lead in blood, 
there are many studies in sub-Saharan Africa on sources of lead.  For example, there were 
a number of studies on levels of lead in paint.  In South Africa, 48% of paint in public 
playgrounds in the municipalities of Johannesburg exceeded the reference level of 1 
mg/cm
2 
 (Mathee et al., 2009). Hazardous levels of lead were also found in domestic paint 
in Nigeria (Adebamowo et al., 2007, Clark et al., 2006, Clark et al., 2009), and Cameroon 
(Gottesfeld et al., 2013). 
 
 
The presence of lead was also found in medicines in Nigeria, where  the  use of herbal 
medicines is reported to result in “lead intakes ranging from 250 μg/day to 27,000 μg/day, 
which were higher than the Provisional Tolerable Weekly Intake ( PTWI) of 25 μg/week of 
lead that was being used at the time” (Obi et al., 2006).  In Nigeria lead was not only found 
in herbal medicines but also in imported western medicinal syrups (Orisakwe and Nduka, 
2009), indicating that  both herbal and ‘western’ medicines may be a potential source of 
lead. 
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Studies have also been conducted on lead in air where, lead concentrations of 1 µg/m
3
 in 
air and 3620 mg/kg in dust were found in air in industrial, commercial, park/beach and 
residential areas of South Africa (Nriagu et al., 1996, Nriagu et al., 1997a) and in  Ghana, 
where the air in areas surrounding a battery, an electronic repair, a welding and  e-waste 
recycling workshops, and a waste disposal site exceeded the contemporary WHO standard 
of 50 μg/m3 (Dartey et al., 2010, Caravanos et al., 2011). 
 
 
Studies on lead in food in Uganda indicated that vegetables grown along heavily trafficked 
streets were heavily contaminated with lead (Nabulo et al., 2006), while in Kenya, fish and 
vegetables were also found to be contaminated with high levels of lead (Makokha et al., 
2008).  In Zimbabwe, high levels of lead were found in vegetables that were irrigated using 
mixtures of wastewater and sewage sludge containing high levels of lead (Muchuweti et 
al., 2006). Lead was also found in processed foods.  For example, in Nigeria, lead was 
found in canned and non-canned beverages (Maduabuchi et al., 2006). 
 
 
There were also studies on lead in other commodities such as toys, crayons and cosmetics. 
For example, in Nigeria, lead was shown to be present in toys (Sindiku and Osibanjo, 
2011, Omolaoye et al., 2010), and in South Africa, lead was present  in crayons (Okonkwo 
and Maribe, 2004).  In South Africa, levels of lead in lipsticks, lip gloss, and foundation 
ranged from below detection limit to 73.1 ± 5.2 mg/g, 4.7 to 11.7 ±  2.8 mg/g, and 7.8 to 
32.9  ± 1.4 mg/g, respectively, with the majority exceeding the United States Food and 
Drug Administration (USFDA) maximum permissible concentration of 0.10 mg/g for lead 
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in cosmetics (Brandao et al., 2012).  High levels of lead were also present in cosmetics in 
Nigeria (Orisakwe and Otaraku, 2013).   
 
 
These and other studies in Africa confirm the possibility of exposure to lead from these 
sources among children in Africa.  They also confirm that although banning the use of 
leaded petrol had a significant impact on BPb in children, other sources of lead may still 
remain, and therefore they may warrant further investigation. 
 
 
1.10 Risk assessment of chemicals 
Risk assessment has been defined as ‘the systematic scientific characterization of potential 
adverse health effects resulting from (human) exposures to hazardous agents or situations’ 
(NRC, 1983). In reference to chemicals the process is specifically referred to as health risk 
assessment (of chemicals) (WHO, 2010b, Filipson et al., 2003), toxicological risk 
assessment (Nielsen et al., 2008), and  risk assessment of chemicals or chemical risk 
assessment (Fryer et al., 2006, Nielsen et al., 2008).  Risk assessment of chemicals is 
conducted  to establish permissible exposure levels for human beings and other species, 
and to assess the health risks resulting from a particular exposure (Filipson et al., 2003).  
Risk assessment is important for risk management, which is defined as the process by 
which policy or other management actions are implemented in order to control hazards 
identified in the risk assessment process. 
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In risk assessment it is important to distinguish between the terms risk and hazard, where 
risk is defined as the probability of the occurrence of an adverse outcome, and the term 
hazard is defined as the intrinsic toxic properties of a chemical.  There is a risk when there 
is exposure to a hazardous substance.  The risk assessment process is said to comprise of 
“four components namely, hazard identification, dose response assessment, exposure 
assessment and risk characterization” (Nielsen et al., 2008). 
 
 
1.10.1 Hazard identification 
Hazard identification aims at “determining if a chemical has an inherent potential to cause 
harm in an experimental animal or in the human body” (Rudén 2006). A chemical is 
declared hazardous only if it produces adverse effects in humans or in experimental 
animals (Abernathy and Roberts, 1994). For human health risk assessment in many 
countries there are lists of tests intended for assessment of toxic effects.  Lead has been 
shown to be a hazardous chemical in in vivo and in vitro toxicological studies and also in 
epidemiological studies discussed in Section 1.6. 
 
 
1.10.2 Dose-response assessment and safe levels for lead 
The Dose-response assessment process evaluates responses at particular exposure levels 
(USEPA, 2005). A response can be any “detectable adverse alteration of morphology, 
functional capacity, growth, development or life span of the target organism“ (Nielsen et 
al., 2008). The increase in incidence or severity of adverse effect depends on the dose, 
which can be defined as the amount of the test substance that comes in contact with the 
organism or part of the organism. However, it is important to note that a chemical enters 
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the body in two steps, the first of which involves contact with the boundary or barrier 
(gastrointestinal tract, skin or lungs) followed by actual crossing of the barrier (absorption).  
The amount of chemical available at the absorption barrier is referred to as the applied 
dose, administered dose, potential dose or intake. Absorption results in the availability of 
the chemical to physiologically significant sites, and the amount of chemical that has been 
absorbed is referred to as the internal dose (Paustenbach, 2010).  The internal dose is 
calculated from the applied dose using bioavailabilities (discussed later in Section 
1.10.3.2).   
 
 
For most chemicals, especially for non-cancer effects, there exists a threshold below which 
exposure to the chemical produces no adverse effect (response) and above which adverse 
effects are experienced.   Therefore, the dose-response assessment aims to identify the No-
Observed-Adverse-Effect Level (NOAEL), the Lowest Observed-Adverse-Effect Level 
(LOAEL), or the benchmark dose (BMD).  The NOAEL is defined as the greatest 
concentration or amount of a substance, found by experiment or observation, which causes 
no response in the target organism under defined conditions of exposure (WHO/IPCS, 
1994, Nielsen et al., 2008).  The LOAEL is defined as the lowest concentration or amount 
of a substance, found by experiment or observation, which causes a response under defined 
conditions of exposure. A typical dose-response curve demonstrating a hypothetical 
NOAEL and LOAEL is shown in Figure 4 below.  This type of dose-response curve, 
where there is no response at lower dose levels, is often referred to as an S-shaped curve.  
However, it is important to note that there are other shapes of dose-response curves, 
including J-shaped, U-shaped and inverted U shaped dose-response curves depending on 
the manner of response (Nielsen et al., 2008). 
51 
 
 
 
Figure 4: A typical dose-response curve 
 
 
The BMD is not a ‘no response level but the “dose that produces a predetermined change 
in response (referred to as  benchmark response [BMR])” (Gephart et al., 2001).  It is 
calculated by fitting experimental data to a dose–response curve, as shown in Figure 5, 
often through the use of a number of dose–response models that are incorporated in some 
BMD software.   
52 
 
 
Figure 5:  Calculation of a BMD (USEPA, 1995b) 
 
 
Using the NOAEL, LOAEL or BMD and with the use of uncertainty or safety factors, the  
international scientific committees such as the Joint Food and Agriculture Organization 
(FAO)/WHO Expert Committee on Food Additives (JECFA) and the Joint FAO/WHO 
Meeting on Pesticide Residues (JMPR), regional scientific committees such as the 
European Food Safety Authority (EFSA), and national regulatory agencies such as the 
United States Environmental Protection Agency (USEPA) could establish acceptable or 
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tolerable intakes of substances that exhibit thresholds of toxicity.  For example, for non-
cancer effects, the WHO derives the Acceptable Daily Intake (ADI), the Tolerable Daily 
Intake (TDI) or the PTWI, whereas the USEPA derives the reference dose (RfD) and the 
Agency of Toxic Substances and Disease Registry (ATSDR) derives minimum risk levels 
(MRLs).  The ADI, TDI and RfD stand for ‘ a daily intake of a chemical which, during an 
entire lifetime, appears to be without appreciable risk’(Lu and Sielken Jr, 1991, Herrman 
and Younes, 1999).  TDI is often used for chemicals that are intentionally added or ‘in 
cases where exposure can be controlled, such as for food additives and residues of 
pesticides’ (WHO/FAO, 2009).   The PTWI, which represents the weekly intake of a 
chemical to which a person can be exposed for their entire lifetime without appreciable 
risk,  is used for contaminants that may accumulate in the body such as lead or cadmium 
(WHO/FAO, 2009).  An MRL is defined as ‘an estimate of the daily human exposure to a 
hazardous substance that is likely to be without appreciable risk of adverse non-cancer 
health effects over a specified duration of exposure’ (ATSDR, 2015). 
 
 
As an example, the RfD is calculated in the following manner: 
 
    
     
         
      Equation 1 
 
where UF is the uncertainty factor.  The number of the uncertainty factors depends on the 
number of uncertainties involved, where a “factor of 10 is used to account for intra-species 
variation, a factor of 10 to account for interspecies variation,  a factor of 10 to account for 
uncertainty resulting from the use of a LOAEL, if a NOAEL cannot be determined, a 
factor of 10 for uncertainty resulting from use of sub chronic toxicity instead of chronic 
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toxicity,  and extra uncertainty factors for other sources of variation” (Gaylor, 1992, 
Vermeire et al., 1993, Pohl and Abadin, 1995). 
 
 
ADIs and TDIs are calculated in a similar manner using uncertainty factors. The use of 
RfD, ADI, TDI and PTWI has a number limitations which include, ‘dependence on the 
background incidence of the health outcome on unexposed animals, dependence on the 
spacing of the doses, and inability to use all available data’ (Barnes et al., 1995).  In 
contrast, the BMD does not have these limitations as the BMD results from statistical 
calculations that utilize all the data, and not just a single point such as NOAEL or a 
LOAEL, makes use of the sample size in its calculation and takes consideration of the 
shape of the dose-response curve (Crump et al., 1995). 
 
 
1.10.2.1 Safe levels for lead 
The derivation of acceptable or tolerable intakes is applicable to chemicals that have a 
threshold of response such as a NOAEL or LOAEL.  Since lead appears to have no 
NOAEL, acceptable or tolerable intakes could not be derived for lead.  However, as early 
as the 1970s it was recognized that dose-response relationships could be established in 
terms of BPb (Zielhuis, 1975, IPCS, 1977).  Consequently, in 1972 the WHO established  a 
PTWI of 50 µg/kg body-weight (b.w.) (JECFTA, 1972), which was meant to keep the level 
of BPb below 10 μg/dL. However, since the 1980s there has been a great number of 
literature that showed that adverse effects of lead may occur at well below BPb levels of 10 
μg/dL, especially in children (Herbert, 2009, Lockitch, 1993, Marjorie, 1985, Nation and 
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Gleaves, 2001).  In order to address this, in 1986 the JECFA set the PTWI for children at 
25 μg/kg b.w. (EFSA, 2010). 
 
 
In the USA, reference values issued by the CDC as guidance on levels of BPb in young 
children have also been changing from 40 μg/dL in 1970,  to 30 μg/dL in 1975, to 25 
μg/dL in 1985, and to 10 μg/dL in 1991 (CDC, 1991).  However, since lead appears to 
have no threshold, the USEPA could not derive an oral RfD for lead (USEPA, 2004). The 
ATSDR also published the Toxicological profile for lead in 2007 without MRLs (ATSDR, 
2007).   
 
 
Internationally, there have also been calls to reduce the levels that are deemed safe for 
lead.  At the  Brescia Workshop in 2006 an action level of 5 μg/dL was recommended the 
worldwide reduction of lead (Landrigan et al., 2007).  Within the same period, some 
researchers also made the recommendation that threshold for BPb should be reduced from 
10 µg/dL to 2 µg/dL (Gilbert and Weiss, 2006).  For this reason in 2010,  the German 
Commission on Human Biological Monitoring (HBM) suspended the HBM values which 
it had set in 1996 (10 µg/dL for children of equal to or less than 12 years and females of a 
reproductive age, and 15 µg/dL for adults) (Wilhelm et al., 2010).  In the same year, the 
EFSA concluded that the PTWI of 25 μg/kg b.w. that was being used then was no longer 
appropriate (EFSA, 2010) and the WHO also decided to withdraw the PTWI of 25 μg/kg 
b.w. for lead after realizing that the PTWI could no longer be considered protective for  
health (WHO, 2011, Zheng et al., 2013).  In 2012 the CDC adopted a new guideline of 5 
μg/dL (Betts, 2012).  Although many countries have adopted the CDC reference value of 
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of 5 μg/dL, an international pooled BMD analysis calculated BMDs ranging from 0.1 
μg/dL to 1.0 μg/dL, indicating that adverse effects could still occur below the CDC 
reference value of 5 μg/dL (Budtz et al., 2013). 
 
 
The proposed intake limit values such as the PTWI and RfD that are established by 
different international agencies are aimed to achieve acceptable levels of lead in blood.  
These agencies have also proposed safe values of lead in different commodities and 
environmental samples with the assumption that exposure to lead through these sources 
may not produce high levels of BPb in exposed individuals.  These values are presented in 
Table 1 below. 
 
 
Table 1:  Safe levels for lead in various countries 
Medium/product Safe level Organization/country 
Paint 90 mg/kg CSPC*, USA 
Paint 1 mg/cm
2
 USEPA 
Paint 600 mg/kg South Africa 
Toys (total lead) 100 mg/kg CSPC*, USA 
Toys (paint) 90 mg/kg CSPC*, USA 
Soil  400 mg/kg USEPA 
Dust 400 mg/kg USEPA 
Dust 40 μg/ft2 USEPA 
Water 10 μg/dL EU# 
Air 0.5 μg/m3 EU 
Air 1.5 μg/m3 USEPA 
Canned fruits and vegetables 0.1 mg/kg  Codex Alimentarius 
Fruit juices 0.03 mg/kg Codex Alimentarius 
Infant formula 0.01 mg/kg Codex Alimentarius 
*CSPC Consumer Product Safety Commission # EU European Union 
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1.10.3 Exposure assessment 
The Exposure assessment process determines the magnitude, frequency and duration of 
exposure (USEPA, 2005).  There are two main approaches in exposure assessment: In the 
bottom-up approach chemicals are measured in environmental media such as air, water and 
food. This approach gives information on external exposures and their sources, but gives 
no information on internal doses. In the top-down approach chemicals are measured in 
bodily fluids or other specimens. This approach, often referred to as biomonitoring, gives 
information on the actual concentrations of a chemical in specified fluids, tissues or 
specimens from an organism.  Although this approach gives some information about the 
internal dose, it, however, does not provide information about sources of exposure 
(Rappaport, 2011). Both approaches (i.e. measurement of lead in environmental media as 
well as biomonitoring) are used in the exposure and risk assessment of lead.  The former 
approach is used to give an indication on the level of contamination of particular media 
(food, water, air, soil etc), which can in turn be converted to potential doses of lead. The 
latter is used in occupational settings or epidemiological studies to give an indication of the 
level of exposure to lead among the participants involved. In order to obtain a complete 
indication of the levels of exposure and risks, measurement of lead in food, air, water, and 
soil should be coupled with measurements of lead in the body.   
 
 
1.10.3.1 Assessment of exposure to lead by assessing internal doses through top-
down approaches 
Most studies on exposure to lead appear to be based on biomonitoring.  Biomonitoring is 
based on the use of biological markers or biomarkers which are defined as ‘systems that 
specifically measure interactions between biological systems and chemical, physical, or 
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biological agents’ (Sanders et al., 2009).  There are three types of biomarkers in toxicology 
termed as biomarkers of exposure, biomarkers of (toxic) effect and biomarkers of 
susceptibility (Timbrell, 1998).  Biomarkers of exposure, biomarkers of effect and 
biomarkers of susceptibility are all used in the biomonitoring of lead, to different extents.    
 
 
1.10.3.1.1 Biomarkers of exposure 
A biomarker of exposure is defined as ‘an exogenous substance or its metabolite or the 
product of an interaction between an exogenous agent and some target molecule or cell that 
is measured in a compartment within an organism to confirm and assess exposure’ (Mross 
et al., 2007).   An exogenous substance is a ‘substance that enters the body from exogenous 
sources such as air, water, diet, drugs, and radiation, as compared to an endogenous 
substance that is produced from processes in the human body such as inflammation and 
lipid peroxidation’ (Rappaport, 2011).   
 
 
Biomarkers of exposure are further subdivided into biomarkers of internal dose and 
biomarkers of effective dose.  Biomarkers of internal dose give an indication that exposure 
to a particular substance has taken place by measuring the concentration of the substance 
or its metabolite(s) in a body fluid or specimen.  Biomarkers of effective dose give an 
indication that exposure to a substance has resulted in the substance reaching the target 
organ or cell (Timbrell, 1998). Biomarkers of exposure to Pb give information on current 
lead body burden in an individual.  Since the body burden of lead is a function of recent 
and/or past exposure,  there is need for selection of the most appropriate biomarkers that 
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suit the intended objective (Barbosa et al., 2005).   Biological samples that are used to 
assess biomarkers of exposure to lead include blood, urine, hair, saliva, bone and teeth. 
 
 
1.10.3.1.1.1 Blood 
BPb reflects past exposure from the past few last months. It is an indication of relatively 
recent exposure in young children that were not excessively or chronically exposed in the 
earlier part of their lives.  The amount of BPb  in heavily exposed children and adults is an 
integration of  BPb of  concentration recent and older exposures (NRC, 1993). Therefore, 
BPb measurement is also used as a measure of chronic lead exposure.  Lead can be 
measured in whole blood, serum or plasma, although lead in whole blood is the most 
widely used biomarker of exposure to lead (Bergdahl et al., 1997c).   
 
 
Blood for lead measurements can be drawn from the vein or capillary.  However, most 
capillary blood specimens have been shown to have falsely elevated lead levels that can be 
traced to contamination (Delves, 1996).  For this reason, the CDC recommends that  
‘capillary BPb measurements may be used for initial screening purposes, whereas venous 
BPb is appropriate for diagnostic evaluation and for initiating an environmental 
investigation or chelation therapy’ (Parsons and Chisolm, 1997).  
 
 
Analysis of BPb concentrations involves chemical modification (by ammonium phosphate, 
or dibasic form of ammonium phosphate), electrothermal excitation (in a graphite furnace), 
60 
 
and measurement using atomic absorption spectroscopy (GFAAS) (Shuttler and Delves, 
1986, Parsons and Chisolm, 1997). 
 
 
1.10.3.1.1.2  Urine 
Since some of the absorbed lead is predominantly excreted in urine, urinary lead (UPb) 
may be used to indicate exposure.  The relationship between UPb and exposure is 
curvilinear upward at high doses (NRC, 1993), making it difficult to directly relate UPb 
and the internal dose of lead.  Furthermore, UPb does not depend only on the body burden 
but also the kidney function. For this reason the  amounts of lead in urine are very variable, 
requiring creatinine correction (Barbosa et al., 2005).  Despite these shortcomings, 
measurement of UPb is a favoured non-invasive approach in long-term biomonitoring 
occupational studies.  UPb is usually determined by GFAAS or anodic stripping 
voltammetry (ASV) after modification with nitric acid (2% volume/volume (v/v)) and 
ammonium dihydrogen phosphate (NH4H2PO4) (Hodges and Skelding, 1981, Parsons and 
Chisolm, 1997). 
 
 
1.10.3.1.1.3 Skeletal system (bones and teeth) 
Since lead accumulates in bones, bones and teeth can be used for biomonitoring of lead.  
Bone lead gives information on lead accumulation and retrospective exposure over a fairly 
long period (NRC, 1993). Non-invasive in vivo bone-Pb measurements using the X-ray 
fluorescence (XRF) methods are becoming increasingly common (Barbosa et al., 2005). 
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Teeth also accumulate lead over the long term.  Therefore, shed teeth can be used to 
measure chronic exposure to lead. Biomonitoring for lead using teeth has many advantages 
including easy collection (after exfoliation) and stability for preservation (Barbosa et al., 
2005).  However, the disadvantage is that interpretation of the data depends on the type  
and part of tooth (IPCS, 1995). Lead in teeth can be analyzed using atomic absorption 
spectrometer (AAS), XRF and laser ablation inductively coupled plasma mass 
spectrometry (LA-ICP-MS) (USEPA, 2006) 
 
 
1.10.3.1.1.4 Hair 
Hair is an attractive biomonitoring specimen because it can be easily and noninvasively 
collected at a minimal cost.  Furthermore, it can be easily stored and transported to the 
laboratory for analysis (Barbosa et al., 2005). However, hair lead measurement is less 
sensitive and less accurate than BPb measurement (Esteban and Rubin, 1999).  In addition, 
the lead that is incorporated into the hair matrix cannot be distinguished from the lead that 
is originating from external sources. The dose response for hair lead is also not well 
characterized (Barbosa et al., 2005). Lead in hair can be measured using Inductively 
Coupled Plasma Atomic Emission Spectrometry (ICP-AES) after digestion in nitric acid 
(HNO3) –hydrogen peroxide (H2O2) (Rao et al., 2002) or Inductively Coupled Plasma- 
Mass Spectroscopy (ICP-MS) (Rodushkin and Axelsson, 2000). 
 
 
1.10.3.1.1.5 Finger nails 
Similar to hair, finger nails can be easily and non-invasively collected and can be easily 
stored and transported to the laboratory for analysis.  Concentration of nail lead reflects 
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long-term exposure since nails are isolated from metabolic activities in the body.  Toe nails 
are preferred to finger nails because they are said to be “less affected by environmental 
contamination than fingernails” (Barbosa et al., 2005).   
 
 
Use of fingers or toe nails lacks reproducibility as there is high variability in lead levels 
measured in the same fingernails or toenails of various subjects (Gulson, 1996).  This lack 
of reproducibility is a serious limitation for using nail lead as a biomarker for lead.  Lead in 
nails can be measured using ICP-MS (Rodushkin and Axelsson, 2000). 
 
 
1.10.3.1.1.6 Saliva 
Saliva has also been proposed as a biological specimen that can be used to assess levels of 
exposure to lead.  However, its utility is limited by uncontrolled variation in salivary flow 
rates, lack of standard or certified reference materials, and absence of reliable reference 
values for human populations, and the very low levels of Pb present in saliva (Barbosa et 
al., 2005).  Whereas a clear relationship could be shown between saliva lead and 
environmental contamination (de Almeida et al., 2009), only a weak correlation could be 
shown between lead in saliva and lead in blood (Barbosa Jr et al., 2006, Costa de Almeida 
et al., 2010).  Lead has been successfully determined in human saliva using combined 
cloud point extraction–capillary zone electrophoresis with indirect ultra violet (UV) 
detection (Luconi et al., 2006) and ICP-MS (Costa de Almeida et al., 2010).  
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1.10.3.1.2 Biomarkers of effect 
A biomarker of effect is defined as ‘a measurable biochemical, physiological, behavioural 
or other alteration within an organism that, depending upon the magnitude, can be 
recognized as associated with an established or possible health impairment or disease’ 
(Mross et al., 2007).  Biomarkers of effect reflect actual biologic responses of the body.  
The critical effects first appear when the concentration reaches a critical level in critical 
organs or tissues (Sakai, 2000).  In lead exposure, critical organs include the central and 
peripheral nervous system, bone marrow, kidney and the digestive system. Critical 
concentrations of lead in the bone marrow can be observed by assessing perturbations in 
the heme biosynthetic pathway and nucleotide metabolisms as per the discussion below.  
 
 
1.10.3.1.2.1 ALAD 
As it was presented in Figure 2, lead directly inhibits the activity of the cytoplasmic 
enzyme ALAD. There is a negative exponential relationship between ALAD and BPb over 
the range of 3–34 μg/dL (ATSDR, 2007).   Therefore, the ALAD concentration (as a 
biomarker of effect) in blood can be used to indicate toxic effects of lead and consequently 
indicate exposure (Sakai, 2000). 
 
 
1.10.3.1.2.2  Extractable protoporphyrin (EP) and Zinc protoporphyrin (ZPP)  
In the final step of the hematopoietic cycle, as shown in Figure 2, the enzyme 
ferrochelatase introduces iron into the protoporphyrin (PP) molecule to form heam. Lead 
inhibits the activity of ferrochelatase and therefore prevents incorporation of iron into 
haemoglobin (NRC, 1993, Barbosa et al., 2005). This results in the increase of the 
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concentration of erythrocyte protoporphyrin (EP) in blood. This reaction also leads to the 
binding of zinc by protoporphyrin, producing zinc protoporphyrin (ZPP) (Onalaja and 
Claudio, 2000).  Therefore, the accumulation of PP or ZPP is a measure of the disturbance 
of the hematopoietic cycle and an indication of the effect of lead in the bone marrow 
(Barbosa et al., 2005).  EP can be measured as free EP (FEP) or ZPP using absorption 
spectrophotometry or fluorometry (Lamola and Yamane, 1975, Sakai, 2000). 
 
 
1.10.3.1.2.3 ALA 
As lead inhibits ALAD activity (Figure 2), ALA accumulates in blood and urine.  
Therefore, ALA in blood, plasma and urine has been used as biomarkers of effects of lead.  
Methods used in the determination of ALA include ion exchange column chromatography, 
high-performance liquid chromatography (HPLC) with fluorescence detection and other 
solvent extraction procedures (Sakai, 2000).   
 
 
 1.10.3.1.3 Biomarkers of susceptibility 
A biomarker of susceptibility is defined as ‘an indicator of an inherent or acquired ability 
of an organism to respond to the challenge of exposure to a specific xenobiotic substance’ 
(Mross et al., 2007).  These are often genetic factors that modify effects in exposed 
individuals.   
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1.10.3.1.3.1 ALAD gene 
Over 99% of BPb accumulates in erythrocytes and more than 80% of this is bound to 
ALAD.  The gene that encodes ALAD exists in two polymorphic forms (alleles), ALAD-1 
and ALAD-2 (Bergdahl et al., 1997b).  This polymorphism  may have an effect on  lead 
toxicokinetics, and therefore can affect the  susceptibility of an individual to lead poisoning 
(Barlow et al., 2001).  Individuals that have the ALAD-2 allele have been shown to have 
higher BPb levels than those that have the ALAD-1 allele (Wetmur et al., 1991, Schwartz 
et al., 2000).  The reason for this is that the presence of ALAD-2 appears to increase the 
retention of lead in blood (Wetmur et al., 1991, Bergdahl et al., 1997b).  In addition, 
ALAD-2 appears to reduce kidney function, which in turn reduces excretion of lead 
(Bergdahl et al., 1997a).  The impact of ALAD genotyope on BPb was also shown in two 
strains of mice that differ in their expression of the ALAD gene.  DBA/2 mice, which have 
a duplication of the ALAD-2 gene, were shown to accumulate twice the amounts of lead in 
blood than C57BL/6 mice (Onalaja and Claudio, 2000).  Consequently, the determination 
of the ALAD genotype is sometimes used to identify individuals that are genetically 
susceptible to higher BPb levels. 
 
 
1.10.3.1.3.2 Vitamin D receptor 
The vitamin D receptor (VDR), which is responsible for many of the biological actions of 
vitamin D, exists in many genetic variations which are referred to as Taq I, Fok I, and 
BsmI.  These genes are  said to be ‘defined by the restriction fragment length 
polymorphisms (RFLPs) that result from cutting the DNA with three different restriction 
enzymes’(Onalaja and Claudio, 2000).  For example, the polymorphism defined by the 
restriction enzyme BsmI results in three genotypes denoted as bb, BB, and Bb, where the 
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capital letter signifies the absence of the restriction site.  Since these genotypes were 
shown to affect calcium and bone density, they were also suspected to play a role in lead 
bioaccumulation.  Indeed, humans with the BB genotype for the BsmI polymorphism or 
with the V genotype for the FokI polymorphism have been shown to have lower BPb than 
those in the other genotype groups (Schwartz et al., 2000, Rezende et al., 2008). Therefore, 
VDR polymorphism can be used as a biomarker of susceptibility. 
 
 
1.10.3.2 Exposure assessment using bottom-up approach by assessing lead in 
food, water, toys, house dust and soil  
Exposure assessment can also be conducted through measurement of the concentration of a 
chemical in the relevant media followed by the estimation of intake.  The intake, which is 
related to the concept of dose, which has been defined in section 1.10.2, is also of much 
importance in exposure assessment studies.  The daily intake is calculated from ingestion 
or consumption data and the concentration of chemicals in the media (food, soil, water, air, 
etc) as follows:  
 
                  Equation 2 
 
where D is the intake (dose) from ingestion of food (mg/kg-day), C is the chemical 
concentration in food (mg/kg), IR is the food ingestion rate (mg/day) (Liu, 1994).  
Therefore, assessment of exposure to a chemical through dust and soil involves sampling 
of dust or the soil, laboratory analysis of the dust and estimation of intake.  Calculations of 
intake from soil and house dust make use of soil ingestion rates from international studies 
conducted on the amounts of dust or soil that children ingest in a day.  Children are 
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reported to ingest 50–200 mg soil/day (Calabrese et al., 1989, Calabrese et al., 1997), and 
the  USEPA recommends 100 mg/day as the average soil ingestion rate and 400 mg/day as 
the upper 95
th
  percentile (USEPA, 2002). 
 
 
Since toys are not ingested, exposure assessment of chemicals from toys would ideally be 
conducted by sampling the toys, analysis of the concentration of the chemical in the toy 
and an estimation of the rate at which the chemical would be released from the toy when a 
child puts the toy in the mouth.  This is a challenging exercise that involves studies of 
speciation of the chemical in the toy matrix, leaching rates of the chemical from the matrix, 
use patterns of the toys and mouthing behavior ((Bosgra et al., 2005).  When information 
on leaching rates, use patterns of the toys and mouthing behavior is available, the computer 
Consumer Exposure (ConsExpo) model can be used to estimate the exposure of a chemical 
from a toy (Bremmer and Veen, 2002).  However, since these are usually not available, 
most studies are only limited to the analysis of the concentration of lead in the toy and 
assessing their safety by ascertaining if the concentration of the lead exceed permissible 
levels indicated in  standards (Greenway and Gerstenberger, 2010, Kumar and Pastore, 
2007, Omolaoye et al., 2010). 
 
 
Dietary exposure assessment involves determination of the concentration of the chemical 
in individual foods and the determination of intake using food consumption data (Kroes et 
al., 2002). In order to determine the concentration of the chemical in the food, food 
samples are usually collected from local markets (Rubio et al., 2005, Schuhmacher et al., 
1991) or from portions of food taken from foods eaten by participants (Muñoz et al., 2005, 
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Schrey et al., 2000).  The food samples from the market can be analyzed as collected or 
they can be used to prepare foods using the most common recipes (Lee et al., 2006).  
 
 
Determination of intake or dose requires food consumption data (or food ingestion rates) 
presented as food consumed per capita per day.  Food consumption data (for exposure 
assessments) are usually obtained through retrospective methods (such as twenty-four-hour 
recall surveys, food frequency questionnaires (FFQs), and diet history surveys) and 
prospective methods such as  duplicate diet (portion) studies and food record surveys 
(FAO/WHO, 2005).  Among the retrospective methods, the most widely used are the 24-
hour recall and FFQ.   
 
 
In the 24- or 48-hour recall method participants are asked to describe the types and 
amounts of all foods and beverages that were consumed in the past 24 or 48 hours, using 
household measures, food models, or photographs (Kroes et al., 2002). However, one 
disadvantage of using this method is that it does not deal very well with the considerable 
variations in individual’s food intake between days (Thompson and Byers, 1994).  Despite 
of these challenges, the 24- (48-) hour recall is often used for dietary exposure assessment 
of many chemicals. 
 
 
The FFQ consists of a structured list of foods and a frequency of its consumption by 
respondents (Żukowska and Biziuk, 2008).  This method assesses food intake over more 
extended periods of time such as 5 days or 7 days.   Portion size aids that are in the form of 
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common household measures such as cups and teaspoons are commonly used to help 
respondents estimate portion size (Thompson and Byers, 1994).  However, food intake 
assessments using FFQs are prone to errors arising from the reliance on memory, or on  
estimation of frequency and portion size  (Beerman and Dittus, 1993). Nevertheless, the 
FFQ has been used for dietary exposure assessment of lead and other chemicals (Ihedioha 
and Okoye, 2013, Kwon et al., 2012).    
 
 
Whereas the 24 hour recall and FFQ involve collection of information retrospectively, 
prospective methods such as food record surveys and duplicate portion studies involve 
provision of dietary information prospectively.  For example, duplicate portion studies 
require the preparation of an exact sample of food consumed by an individual for a period 
of 3 to 7 days.  This approach provides not only information on the exact types and 
amounts of food consumed by an individual, but also an exact sample for laboratory 
analysis (WHO, 1985).  Although prospective dietary assessment methods are not prone to 
errors that arise from the reliance on memory, or on estimation of frequency and estimation 
of amounts, they are expensive and challenging to conduct.  In addition, they suffer from 
bias as participants change dietary habits when they recognize that they are under 
observation.  Despite these challenges, duplicate portion studies are often used for dietary 
exposure assessment of lead (Lacey et al., 1985, Stanek et al., 1998, Wilheim et al., 2003).   
  
 
1.10.3.3  Conversion of measurements from the bottom-up approach to BPb 
Health risk assessment of lead requires conversion of the information on lead intake (from 
food, water, soil etc) into BPb (for the reasons that are explained later in Section 1.10.3.4). 
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This conversion is achieved through the use of biokinetic models, an example of which is 
the IEUBK model.    The IEUBK model attempts to predict BPb concentrations for 
children between 1 and 6 years of age exposed to lead in their environment. The model 
allows the user to input relevant absorption parameters (e.g., the fraction of lead absorbed 
from food) as well as intake and exposure rates. A schematic representation of the model is 
shown in Figure 6 below.   
 
Figure 6:  Schematic representation of the IEUBK model (USEPA, 1994a)  
 
Conversion of administered dose (or intake) to BPb also requires use of bioavailability.  
This is important because not all of the lead that is ingested or inhaled is absorbed. 
Bioavailability is defined as the ‘proportion of lead considered to be extracted in the 
gastrointestinal tract or lungs compared with the total lead that has been ingested or 
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inhaled’ (Gulson and Davis, 1994).  Lead can exist in various forms including lead from 
cars (PbClBr and PbSO4), lead from minerals(PbS and PbCO3), and  lead from paint 
(PbCO3Pb(OH)2 and PbCrO4) (Chaney et al., 1989).  Different forms of lead appear to 
have different bioavailabilities (Freeman et al., 1992).  Different bioavailabilities are 
reported in the literature for dietary lead:  a 10% or lower (Rabinowitz et al., 1980, Heard 
et al., 1983),  around 20% (Kostial and Kello, 1979),  around 31% (Hallén and Oskarsson, 
1995), around 40% (Ziegler et al., 1978) and about 70% (Kostial et al., 1971).  The IEUBK 
model uses a very conservative default figure of 50% for lead bioavailability in food 
(USEPA, 1994a).  Ideally, the bioavailabilities of lead from soil or food should be 
determined empirically for each site. 
 
 
The applications of the IEUBK model can be summarized as follows: 
 Determination of predicted values of BPb resulting from exposures to different 
sources (Wang et al., 1997, Khoury and Diamond, 2003, Lynch et al., 2000); 
 Estimation of the contribution of a single source of lead (e.g. tap water) to BPb (Li 
et al., 2016, Sathyanarayana et al., 2006, Wang et al., 2011) and subsequent 
determination of exposure routes (Cornelis et al., 2006); this is often achieved by 
entering information on a single source only into the model; 
 Estimation of the concentration of lead in soil that would result in a predetermined 
percentage of children (such as 10%) not having BPb 5 µg/dL(Cornelis et al., 2006, 
von Lindern et al., 2003, Rasmuson et al., 2012); this estimation is often performed 
for remediation of contaminated sites. 
 
 
72 
 
In addition to the IEUBK model, there are also other models that are used for simulating 
BPb that can be used in the exposure assessment to lead from different sources.  For 
example, the Carlisle and Wade model is used by the California EPA to predict BPb from 
food, drinking water, soil and dust. The model is more suitable for adults than for children 
(LaKind, 1998).  The California Department of Toxic Substances Control LeadSpread 
model is used to estimate BPb concentrations that may result from exposure to lead via 
inhalation, ingestion or dermal contact with contaminated media (CDTSC, 2007).  The All-
Ages Lead model (AALM) simulates lead concentration in body tissues and organs from a 
lifetime of exposure to lead (USEPA, 2012).  The O’Flaherty physiologically-based 
toxicokinetic (PBTK) model can be used to estimate the distribution of lead in the body 
especially in blood and bones (Oflaherty, 1993).  
 
 
1.10.4 Risk characterization of lead  
In the traditional risk assessment paradigm, assessment of intake or dose is followed by 
risk characterization, a step that integrates information from the hazard identification 
(Section 1.10.1), dose-response assessment (Section 1.10.2 ) and exposure assessment 
(USEPA, 1995a). For most chemicals, risk characterization for non-cancer effects is 
achieved by calculating the Hazard Quotient (HQ) as follows: 
 
                     Equation 3    
where:                       
DI = Daily Intake (mg/kg-day)  
RfD = Reference Dose (mg/kg-day)  
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There is no risk if the HQ for a chemical is equal to or less than one.  If the HQ exceeds 1, 
there is some possibility that some effects may occur (EPA, 2011, Williams and 
Paustenbach, 2002).  Risk can also be characterized using the margin of exposure (MOE) 
or margin of safety (MOS) where 
                    Equation 4 
 
MOEs in the range of 100–1000 are considered safe (USEPA, 2000). 
 
 
These approaches may not be applicable to lead for the fact that lead has no RfD, ADI or 
PTWI.  Many dose-response relationships have however been identified for many adverse 
effects of lead that could be correlated to the levels of BPb as indicated in Table 2. Using 
these thresholds or cut-off points, the predicted (or measured) BPb are correlated with 
potential health effects.  In other words, ‘BPb concentrations are the metric used to 
integrate exposure estimates and predict the likelihood of health hazards associated with 
lead exposure’ (Mahaffey, 1998).   
 
Table 2:  BPb thresholds for health effects of lead (WHO, 2003a) 
Outcome  BPb threshold 
Reduction in IQ 5 µg/dL 
Increased systolic blood pressure ND 
Gastro-intestinal effects 60 
Anaemia 70 
ND No documented effects or insufficient evidence 
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1.10.4.1 Estimation of the burden of disease of mild mental retardation 
(MMR) attributable to lead exposure to children 
An estimation of the burden of disease is a quantification of the burden of premature 
mortality and disability for major diseases or disease groups (Mathers and Woodward, 
2003).   The burden of disease is an ‘indicator that helps in identifying disadvantaged 
groups and targeting of health interventions, and setting of priorities in health service and 
research’ (Murray, 1994).  The burden of disease can be assessed at a global level, national 
level or sub- national level such as a city or district (Prüss-Üstün et al., 2003a).  In the case 
of lead, the burden of disease from Pb exposure converts BPb distribution to actual impacts 
of the lead exposure in figures with which policy makers are conversant. It highlights the 
magnitude of disease burden that could be avoided so that information on the disease 
burden can enable policy makers to correctly direct interventions on the specific risk 
factors.   
 
 
Burden of disease estimates are usually reported as measures of population health, such as 
the disability-adjusted life year (DALY) (Murray and Lopez, 1996).  The DALY is the sum 
of years of life lost due to death and years of life with disability, where each disease 
condition is attributed a defined severity weight.   The DALY therefore measures the 
health of a population by combining data on mortality and morbidity outcomes into a 
single number (Prüss-Üstün et al., 2003b).  It attempts to combine disease occurrence and 
severity and it attempts to quantify the impacts of a disease on the health, psycho-social 
and economic well being of individuals and populations in one measurement unit.    
According to the WHO ‘one DALY can be thought of as one year of "healthy" life lost 
whereas the sum of DALYs across the population can be thought of as a measurement of 
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the gap between current health status and an ideal health situation’ (WHO, 2015). 
Calculation of DALYs for various diseases can enable comparison of the impacts of 
various diseases, which is important for prioritization of resources. 
 
 
The WHO has produced general guidelines on methods for estimating burden of disease 
(Mathers and Woodward, 2003) and also specifically a guideline for estimating the burden 
of disease attributable to exposure to lead (WHO, 2003a).  The guideline has been used to 
estimate the burden of disease in various contexts.  A global estimate of the burden of 
disease from exposure to lead was made in 2004 (Fewtrell et al., 2004) and a number of 
estimates for burden of disease attributable to lead have also been performed for various 
countries and regions (Jarosińska et al., 2006, Landrigan et al., 2002, Norman et al., 2007).  
The guideline is under revision by the WHO in order to incorporate recent findings on the 
effects of lead (WHO, 2003b). This guideline is however been used in the present study to 
obtain conservative estimates only.  
 
 
The main toxicity end points for lead in children include MMR (at BPb ≥ 5 µg/dL), gastro-
intestinal problems (60 µg/dL) and anaemia (at BPb ≥ 70 µg/dL) (WHO, 2003a).   Most 
studies on Pb focus on IQ losses resulting in MMR.  In this regard, IQ loss is not 
considered to be a disease by itself.  Instead IQ losses are converted into cases of MMR 
where MMR is defined as having an IQ score of 50–69 (Fewtrell et al., 2004). IQ in human 
populations has a normal distribution with a mean of 100 and a standard deviation of 15 IQ 
points (Lezak, 2004). Children with an IQ scores just above 69 are at the greatest risk of 
lead-induced MMR. Therefore, as portrayed in Figure 7 below, it is important to calculate 
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the number of children with IQ just above the threshold of IQ score 70, whose IQ would 
shift to the MMR range through IQ reduction due to lead exposure. 
 
 
 
Figure 7:  Shift to MMR as a result of lead-induced IQ loss (WHO, 2003a) 
 
In the dose-response relationship for lead, loss in IQ points vary according to BPb levels:  
The average loss of IQ points for the 5–10 μg/dl interval is taken as 0.65, that for <10 to 15 
as 1.95 IQ points, that for the < 15 to 20 as 3.25 IQ points and that for blood lead < 20 is 
taken as 3.5 IQ points. This information is incorporated into the WHO lead burden of 
disease spreadsheets that are used to calculate the burden of disease. The prevalence of 
MMR is subsequently estimated by multiplying the number of children within the IQ 
points loss category with the respective percentage of the population within that 
concentration range. 
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1.10.5  Summary of approaches in the exposure assessment of lead 
The advantages and disadvantages of the approaches used in the exposure assessment of 
lead have been summarised in Table 3 below.  The table indicates that utilization of top-
down approaches (biomonitoring) alone does not provide much information on the sources 
of exposure.  Utilization of bottom-up approaches (measurement in environmental media) 
on the other hand provides information of the sources without indicating the internal dose 
among participants.  Therefore, in the present study both top-down approaches and bottom-
up approaches were utilised to obtain a complete understanding of internal exposure levels 
and the sources of exposure to lead.  Furthermore, biomonitoring using blood has been 
utilised in this study because it is the most widely used specimen in the risk assessment of 
lead, and also because it reflects past exposure from the past few months.  As a widely 
used specimen in the risk assessment of lead, BPb has well-characterized dose-response 
relationships and is more easily comparable to other studies.    Also, since BPb reflects past 
exposure from the past few months, BPb offers a wider picture of the levels of exposure to 
lead among children in a cross-sectional study that can only give a snap-shot of the 
exposure levels. 
 
 
Table 3 also shows the need for conversion of levels of lead in different environmental 
media to BPb.  This is necessary for risk characterization lead as lead has no RfD. In the 
present study the conversion of environmental lead to BPb was achieved using the IEUBK 
model because it is the most widely used in literature, it has been validated and has been 
shown to give accurate results, and because it is freely available on the internet.   
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Table 3:  Summary of approaches in the exposure assessment of lead 
Method Advantages  Disadvantages  
Biomonitoring using 
blood 
Reflects past exposure 
from the past few 
months. 
Easy to collect and 
determine  
Does not indicate the sources 
Biomonitoring using 
urine 
Non-invasive and 
painless collection 
Does not indicate the sources 
UPb also depends on kidney function 
Biomonitoring using 
the skeletal system 
 
Indicates accumulated 
lead. Non-invasive 
collection and 
measurements 
Does not indicate the sources 
 
Biomonitoring using 
hair 
Easily and noninvasively 
collected  
Does not indicate the sources 
Not very sensitive and accurate  
Biomonitoring using 
finger nails 
Easily and noninvasively 
collected 
Does not indicate the sources 
lacks reproducibility 
Biomonitoring using 
saliva 
Easily and noninvasively 
collected 
Does not indicate the sources 
Uncontrolled variation in salivary flow 
rates, lack of standard or certified 
reference materials and reference 
values 
Biomonitoring using 
ALAD 
Biomarker of effect 
indicates level of damage 
Does not indicate the sources 
Lack of reference values  
Biomonitoring using 
EP and ZPP 
Biomarker of effect 
indicating level of 
disturbance of the 
hematopoietic cycle  
Does not indicate the sources 
Lack of reference values 
Biomonitoring using 
ALA 
Biomarker of effect 
indicating level 
inhibition of ALAD 
activity 
Does not indicate the sources 
Lack of reference values 
Biomonitoring using 
ALAD gene  
May be used to identify 
genetically susceptible 
individuals  
Does not indicate the sources 
 
Biomonitoring using 
VDR 
May be used to identify 
genetically susceptible 
individuals  
Does not indicate the sources 
 
Environmental 
measurement of lead 
in media (food, air, 
water, soil)  
Indicate level of 
contamination in the 
sources 
Does not indicate internal exposure 
 
24 hour recall Easy for participants to 
remember food 
consumed in the past 24 
hours 
Cost-effective 
Has been shown to have large intra-
individual and inr-individual variability 
May not show foods consumed on 
weekends or during the week 
Depends on recall 
Susceptible to bias 
FFQ Captures foods Very difficult for participants to 
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Method Advantages  Disadvantages  
consumed over many 
days 
Cost-effective 
remember foods consumed in the past 
few days 
Depends on recall 
Susceptible to bias 
Food diary Captures foods 
consumed prospectively 
Does not depend on 
recall 
Susceptible to bias 
Time consuming 
Requires more resources 
Conversion of 
environmental 
measurements in 
media to BPb 
Indicates internal 
exposure that can permit 
risk characterization 
It is data intensive 
IEUBK model Validated 
Specifically for children 
Widely used 
Freely available  
Available in software 
format 
Data intensive 
Carlisle and Wade 
model 
 Not available in software format 
Validation status not clear 
Primarily for adults 
Not freely available on the internet 
Not widely used 
Data intensive  
The All-Ages Lead 
model (AALM)  
For all ages  
Freely available  
Available in software 
format 
Not widely used  
Validation status not clear 
Data intensive 
 
The O’Flaherty 
PBTK  
For all ages Not available in software format 
Validation status not clear  
Not widely used 
Data intensive 
WHO burden of 
disease spreadsheet 
Estimates burden of 
disease of mild mental 
retardation (MMR) 
attributable to lead  
It is still under revision 
 
2.0 Methodology  
This chapter aims to describe the methods and approaches used to recruit participants, 
collect samples and specimens, collect food consumption data, collect information on potential 
risk factors, analyze for lead in the samples and specimens, statistically analyze the data, 
predict blood lead from food, water, house dust and soil, assess the applicability of the 
model to Malawi, correlate predicted and measured blood lead levels to potential health 
effects, assess the burden of disease and identify risk factors. 
 
 
2.1 Study design 
This study is a descriptive cross-sectional epidemiological study conducted within the 
paradigm of toxicological (health and environmental) risk assessment of chemicals.  
However, it should be noted that the risk assessment for lead follows a slightly different 
approach from the traditional risk assessment approach because of the lack of RfD, ADI, 
TDI or PTWI for lead.  The risk assessment of lead that has been followed in the present 
study involved the following steps: 
1. Measurement of the levels of BPb of the participants. 
2. Measurement of the levels of lead present in different sources. 
3. Calculation of the predicted BPb values resulting from exposure to lead from the 
identified sources. 
4. Evaluation of the applicability of the IEUBK model by assessing the agreement 
between the measured to predicted BPb values. 
5. The identification of the sources of exposure to lead, once the model has been 
evaluated. 
6. The identification of potential risk factors using the measured BPb levels. 
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2.2 Study setting and study population 
Blantyre City is the commercial capital city of Malawi, which is situated in Southern 
Africa (Figure 8).   
 
Figure 8: Map showing the location of Malawi in Africa and the location of Blantyre in 
Malawi (Courtesy of LACOSUS) 
 
The study population included children between 1-6 years of age, who had lived at the 
residence for at least six months prior to enrollment. Children that were still under breast 
feeding were excluded. According to the 2008 census Blantyre has around 81,717 children 
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in the 1-4 year bracket and 83,747 children in the 5-9 year bracket (NSO, 2008).  The 
population of the age group 1-6 years can therefore be estimated to be over 100,000. 
 
 
Blantyre is divided into 6 health catchment areas which are served by six main health 
centres.  These areas are Machinjiri, Chilomoni, Ndirande, Limbe, Zingwangwa and 
Bangwe (Figure 9).  Blantyre has many residential, commercial and industrial areas, with 
some of the residential areas in close proximity to industrial areas.  However, there are no 
known industrial or mining activities (such as lead mining and smelting, thermal power 
stations, incinerators or waste recycling) in Blantyre that can result in occupational and 
environmental exposure to lead.  Furthermore, in spite of other possible industrial sources 
of lead, the introduction of regulations on lead in gasoline in many countries has been 
shown to reduce the concentrations of lead in air (Thomas et al., 1999, Li et al., 2016).  For 
this reason air lead concentrations in the present study were not determined and the IEUBK 
default value of 0.1 µg/m
3
 was utilized.  
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Figure 9:  Map of Blantyre showing the 6 health catchment areas (Courtesy of Land 
Consultancy and Surveying Services (LACOSUS)).  The red dots are the locations where 
the participants resided. 
 
 
2.3 Recruitment of children 
Ethical approval was sought from the University of the Witwatersrand Committee for 
Research on Human Subjects (No M120662) (Appendix 3) as well as from Malawi College 
of Medicine Research Ethics Committee (COMREC) (No. P.09/12/1282) (Appendix 3).  
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The sample size was calculated based on lead exposure from Botswana (Mbongwe et al, 
2005) because it is a country in the region with similar socio-economic characteristics.  
Consequently, with an expected average BPb of 8.8 µg/dl, the sample size was calculated 
as follows (Daniel, 1995, Naing et al., 2006):    
 
  
   
 
  
         Equation 5        
where  
n = number of children 
Zα = standard normal deviate corresponding to a 2 sided level of significance of 5% = 1.96 
σ = standard deviation of lead level from previous study = 5.6 µg/dl  
d = level of precision = 1 µg/dl 
n = 120 
 
 
Therefore, the minimum sample size was 120. After adjusting for non-response rate of 
50%, the targeted minimum number of children in the study was 240, which comprised of 
40 children from each of the 6 health catchment areas of Blantyre.  Therefore, after 
introducing the project to community leaders, 40 names of eligible children were randomly 
chosen from the community nurses’ and health surveillance assistants’ (HSAs) register in 
each health catchment area.  Study information sheets written in both English and the 
vernacular Chichewa were given to the children’s parents or guardians.  The study 
information sheets were read by the researchers to parents or guardians that could not read.  
Only individuals that consented to take part in the study were enrolled. In addition, 
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children between 4 and 6 years were asked to assent to take part in the study.  Randomly 
allocated numbers were used to maintain confidentiality.   
 
 
The refusal rate was very high with the result that extra names were drawn from the 
registers.  There were large differences in the willingness to participate in the study 
according to health catchment area. In total, a152 children were recruited from 310 
participants that were contacted in all the catchment areas.  Therefore, the refusal rate was 
about 51%, with more children participating in some catchment areas than others.   
 
 
2.4 Sampling and sample collection of blood, paint, food, water, house dust 
and soil 
2.4.1 Blood 
One millimetre venous samples of whole blood were drawn into Vacutainer tubes with 
techniques designed to ensure minimal extraneous lead contamination, as is recommended 
in the literature (Parsons and Chisolm, 1997, WHO, 2010a). These samples were stored at 
4-6 
o
C at the College of Medicine laboratory awaiting transportation to Lancet laboratories 
in South Africa for analysis. 
 
 
2.4.2 Paint (fresh paint and paint chips) 
One sample each of the common colours of paint  (red, orange, yellow, green, blue, black,  
and white) available for each common brand (both imported and locally made) were 
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purchased from paint hardware and building supply stores that are used by the general 
public.  This approach has also been followed in similar studies (Clark et al., 2006).  
 
 
The sampling approach for paint chips was similar in many aspects to the approaches 
recommended by the United Stated Housing and Urban Development   (USHUD, 1997, 
MDCH, 2004).  Wherever owners of the house would allow, paint chips were scraped from 
a small area using a builder’s knife, which was then washed and wiped dry after each use 
to avoid cross contamination. The paint chips were collected into 50 ml sample bottles.  
Lime (CaO) or white wash was not considered as paint. 
 
 
2.4.3 Toys 
Children’s toys were acquired from main markets in Blantyre, i.e. Blantyre market and 
Limbe, using similar approaches as in the literature (Greenway and Gerstenberger, 2010). 
 
 
2.4.4 Food and water 
Samples of the most commonly consumed foods were acquired from the market in the 
health catchment area concerned, as recommended in the WHO guidelines (WHO, 1997).  
Wherever necessary, the food was prepared by a few women from each catchment area 
using the most common methods of preparation.  The foods were then stored at -20 
o
C at 
the College of Medicine cold room.   
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Water (250 ml) sample was drawn from the homes of the participants at any random time 
of the day, as is commonly practiced in literature (Haider et al., 2002).  The samples of 
water were then stored at -20 
o
C at the College of Medicine cold room. 
 
 
2.4.5 House dust and soil 
Floor dust samples were collected from the children’s bedroom wherever possible or in the 
lounge, using a broom or brush from each particular home.  Use of broom or brush for 
sampling dust is a method that is also recommended in the literature (Lewis et al., 1994, Li 
et al., 2016).  Other methods for sampling house dust that are also found in the literature 
include wipe sampling methods and use of vacuum cleaners (Farfel et al., 1994, Sterling et 
al., 1999). In some cases, samples of dust were obtained from the school that the children 
were attending. The dust samples were not touched with bare hands to avoid 
contamination, as is recommended by the US Department of Housing and Urban 
Development (HUD) (USHUD, 1997). 
 
 
Two samples of surface soil from the children playground at home were collected into a 
sample container (60 ml bottles) by a scoop.  In some cases, samples of soil were also 
collected from the playground at the school that the children were attending. Once again, 
the soil samples were not touched with bare hands to avoid contamination,  
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2.5 Laboratory analysis of lead in different samples  
Blood samples were analyzed at Lancet Laboratory in Johannesburg South Africa whereas 
dust, soil, food, water, paint and toy samples were analysed at Protechnik laboratory (a 
Division of Armscor SOC Ltd) in Pretoria South Africa, both of which being accredited 
commercial laboratories that participate in national and international quality control 
programmes. 
 
 
2.5.1 Lead in blood 
Whole blood samples were diluted ten times by adding 100 µl of each blood sample to 900 
µl of diluent (10% Triton X-100).  Analysis was performed on a Varian SpectrAA 220Z 
GFAAS. The instrument was calibrated with calibration standards prepared in sheep blood 
for matrix matching. Aliquots of each sample were analyzed in duplicate at 283.3 nm.  
Two certified reference controls, UTAK Metals Control in whole blood (UTAK 
Laboratories Inc., Valencia, CA, USA) were analyzed with every analytical run in intervals 
of 10 samples for quality assurance of the measurement. The detection limit (three times 
standard deviation of all blank samples) for lead in whole blood was 1 μg/dL and the 
uncertainty of reading was 14.5%. 
 
 
2.5.2 Lead in paint 
Analysis of lead in paint was conducted in line with the American Consumer Product 
Safety Commission (CSPC) guidelines (CPSC, 2011). Fresh paint was stirred and applied 
by brush to pre-cleaned petri dishes and left to dry for a minimum of 72 hours and further 
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dried in the oven at 105 
o
C. The paint was then carefully removed from the petri dishes 
using a clean unused knife.  
 
 
Fresh paint samples and paint chips from home were analyzed using In-house ICP/MS 
method based on NIOSH 7300, EPA 2007.7 and 8 and ISO 15202-3. 
 
 
2.5.3 Lead in toys 
Analysis of lead in toys was conducted in line with the CSPC guidelines for analysis of 
lead in toys (CPSC, 2008).  Samples were ashed to break down the plastic material and 
then digesting it in accordance with EPA SW-846 3050 (digestion with HNO3 and H2O2. 
The final processed samples were quantitatively analyzed using ICP-MS.    
 
 
2.5.4 Lead in food and water 
A known weight (approximately 2g) of sample was dry-ashed at 420 
o
C.  Ashed samples 
were dissolved in 10 ml 0.25% HNO3.  The lead concentrations were then determined by 
ICP-MS.  Water samples were acidified before determination of lead using an ICP-MS 
method based on NIOSH 7300, EPA 2007.7 & 8 and ISO 15202-3. 
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2.5.5 Lead in house dust and soil 
House dust and soil lead were digested in nitric and perchloric acids. The filtered solutions 
were analyzed for lead by graphite furnace AAS at a wavelength of 217 nm using an ICP-
MS method based on NIOSH 7300, EPA 2007.7 & 8 and ISO 15202-3. 
 
 
2.6 Food consumption data 
Food consumption data was collected using a 7-day FFQ (Appendix I).  The questionnaire 
was adopted from the Birth-to-Twenty cohort study with the types of food consumed taken 
from the Malawi Second Integrated Household Survey (IHS) household characteristics, 
income and expenditure questionnaire (NSO, 2004).  Food conversion factors were 
adopted from the South African Medical Research Council (MRC) Food Photo manual 
(Senekal and Steyn, 2004) and the Malawi Third IHS 2010/11 Data (NSO, 2013). In the 
cases where the conversion factor for some food standard portions were not available from 
these sources, the most commonly used unit portions (such as the flat wooden serving 
spoons locally known as chipande) were measured at least 5 times and used in the 
conversion factor. 
 
 
2.7 Collection of data on risk factors 
Information on potential risk factors was collected using a lead exposure risk assessment 
questionnaire attached in Appendix 1, which was adopted from Illinois Department of 
Public Health (IDPH) Public Health Home Visit Form for Environmental Health and Lead 
Assessment (IDPH, 2011) 
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2.8  Data Processing and analysis 
Data were entered into Microsoft Excel 2007 spreadsheets, cleaned and then transferred to 
STATA version 12 statistical package spreadsheets for analyses.   
 
 
2.9 Predicting blood lead from food, water, house dust and soil 
The USEPA recommends that when calculating exposures from ingestion, the unit of 
weight used to measure intake should be consistent with the unit used in measuring the 
contaminant concentration in the produce (USEPA, 1997).  In the present study, the 
analysis of Pb in food was based on dry weight.  However, the food consumption rates as 
given by parents were based on wet foods.  For this reason it was important to analyze the 
moisture content of the foods.  Wherever the Pb content of a food item was expressed per 
mass of the food item, moisture content was corrected using the following equation 
(USEPA, 1997, Jang et al., 2014):  
 
         
(     )
   
       Equation 6 
 
Where IRDry is the average consumption rate of the food item on a dry basis, IR is the 
average consumption of the food item as given in the FFQ and M is the moisture content of 
the food.   
 
 
The calculated IRDry could then be used in equation 2 in section 1.10.3.2 to calculate the 
dietary intake (dose).  These dietary intake values were then used in the IEUBK, in the 
dialogue data window, an example of which is shown in Figure 10 below.  The IEUBK 
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model default bioavailability of 50% and a 31% value from the literature were used in the 
present study to assess which bioavailability would result in a better agreement between 
predicted and measured BPb.  The default value is the value recommended for the model. 
 
 
 
Figure 10:  IEUBK window for dietary data 
 
The soil concentrations, the IEUBK model default bioavailability of 30% and the soil 
ingestion data (Table 3) were utilized in the IEUBK model soil data dialogue window, an 
example of which is shown in Figure 11 below.   
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Table 4:  IEUBK Soil/Dust Ingestion Defaults by Age (USEPA, 1999) 
 
Age Group (years) IEUBK Model Defaults (g/day) 
0-1 0.085 
1-2 0.135 
2-3 0.135 
3-4 0.135 
4-5 0.100 
5-6 0.090 
6-7 0.085 
 
 
 
Figure 11:  IEUBK window for soil and house dust data 
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2.9.1 Assessment of model performance 
Model performance was assessed by calculating the Pearson (product-moment) correlation 
coefficient, modelling efficiency (ME), the Nash-Sutcliffe efficiency (NSE), the Root 
Mean Deviation (RMD), the ‘95% limits of agreement method’, and by using the paired 
student’s t test.  Since each one of model performance criteria emphasizes on different 
aspects of model performance, it is important to use a combination and not just one 
criterion.   
 
 
The Pearson correlation coefficient (r) is used to determine if there is a relationship 
between two sets of paired numbers, in this case the measured and the predicted BPb 
values.  It measures the degree of collinearity between predicted and measured data,  with 
values ranging from +1 to -1, where a value of 0 indicates lack of correlation between two 
variables, + 1 indicates a positive correlation and -1 indicates a negative correlation with 
the implication that the latter two values are positioned on the same line (Bruning and 
Kintz, 1987).  The Pearson Correlation coefficient used in the present study was calculated 
using STATA Version 12. It has often been argued, with good reason, that the Pearson 
Correlation coefficient is not a good measure of agreement.  For this reason, it was used in 
this study as a starting point, and was supplemented with other approaches.   
 
 
ME compares the efficiency of the model to the efficiency of describing the data using the 
mean of the observations.  Since the normal distribution curve has an optimum at the 
mean, the mean value has the highest probability of occurrence. Consequently, the mean is 
often called the "expected value" since it is a value most expected in random observations.  
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In this regard, the mean BPb for a population describes the expected or most likely value 
from a child selected randomly.  The modelling efficiency is a criterion that measures 
whether the model provides a better prediction of BPb than merely using the sample or 
population average. The ME is calculated as follows:  
 
    
∑ (      )
  
    ∑ (     )
  
   
∑ (      )
  
   
     Equation 7 
 
Where Pi is the predicted BPb value, Oi is the observed or measured BPb value, OAv is the 
average of the observed values and n is the number of values (Scorza Júnior and Boesten, 
2005). The Values of ME range from -1 to +.  A positive value of ME indicates that the 
predicted values provide a better trend than the mean of observed values, whereas a 
negative value of ME indicate that the predicted values do not describe the trend better 
than the mean of observed values (Smith et al., 1997, Li et al., 2016).  
 
 
It is important to note that the ME, is based on the arithmetic mean, which does not 
perfectly describe the central tendency for data that are not normally distributed.  On the 
other hand,  the ME analyses the effect of outliers and variability (spread) by considering 
the difference between observed BPb and the average BPb (Oi - Oav) and/or the difference 
between predicted BPb and average BPb (Pi - Oav).  Nevertheless, the ME may result in 
overestimation of large values and under-estimation of lower values since the differences 
between the observed and predicted values are calculated as squared values 
 
 
 
96 
 
NSE is a “statistic that determines the relative magnitude of the residual variance compared 
to the measured data variance” (Moriasi et al., 2007).  It can be computed using the 
following equation: 
 
      
∑ (     )
  
   
∑ (      )
  
   
      Equation 8 
 
Where Oi is the observed or measured BPb value at a particular place or time i, Pi is the 
predicted  BPb value at a particular place or time i and OAv is the average of the observed 
values. NSE indicates how well the plot of measured versus predicted data fits the ‘1:1 
line’.  NSE values range between −∞ and 1.0, with an optimal value of 1, where “values 
between 0 and 1 are generally viewed as acceptable levels of performance, whereas values 
<0.0 indicates that the mean observed value is a better predictor than the simulated value, 
which indicates unacceptable performance” (Moriasi et al., 2007).  Since the closer the 
NSE is to 1, the more accurate the model is, NSE therefore provides a measure of accuracy 
for a model.   The NSE shares the shortcomings of the ME due to the use of an arithmetic 
mean and squared values of the differences between the observed and predicted values 
(Krause et al., 2005).  On the other hand, the NSE also analyses the effect of outliers and 
variability (spread) by considering the difference between observed BPb and the average 
BPb (Oi - Oav) and/or the difference between predicted BPb and average BPb (Pi - Oav)  
 
 
The RMD is a parameter that evaluates systematic bias in the model, with values close to 0 
indicating absence of bias (Li et al., 2016).  It can be calculated using the following 
equation: 
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       Equation 9 
 
Similar to the ME and the NSE, the RMD is based on the arithmetic mean which does not 
perfectly describe the central tendency for data that are not normally distributed.  On the 
other hand, the RMD analyses the effect of outliers and variability (spread) by 
incorporating the difference between predicted BPb and observed BPb (Pi – Oi) for all the 
ranges of measurements including outliers.   
 
 
The 95% agreement method is a simple statistical approach in which the difference 
between measurements on the same individual from two methodologies implemented is 
plotted against the mean of the two measurements.  In this approach, the 95% of 
differences between measurements are expected to be within the mean difference of  ± 2 
standard deviations (Bland and Altman, 2010).  Furthermore, the paired student’s t test 
determines if there is a significant difference in the means of independent paired data.   
 
 
In addition to the assessment of accuracy, bias, level of agreement between predicted and 
measured BPb values, a sensitivity analysis was conducted to assess the sensitivity and 
specificity of the model, where sensitivity is defined as “the proportion of true positives 
that are correctly identified by the test”, whereas specificity is defined as “the proportion of 
true negatives that are correctly identified by the test”(Altman and Bland, 1994).   
 
 
98 
 
2.9.2 Estimating the contribution of soil and food to measured blood lead 
The IEUBK model was used to assess the contribution of soil and food to BPb by entering 
the required data for each source (i.e. food and soil) separately into model and taking the 
percentage of the resulting BPb against measured BPb. 
 
 
2.10 Relating the resulting BPb levels to potential health effects  
Potential health effects were assessed in terms of BPb concentrations using cut-off points 
or thresholds for BPb concentrations for various health outcomes, as shown in Table 2, 
presented in Section 1.10.3.4. The table shows that reduction of IQ starts at BPb levels of 5 
µg/dl, gastro-intestinal effects at 60 µg/dL and anaemia at70 µg/dL.  The prevalence data 
from the measured and predicted BPb was used to estimate the percentage of children that 
would be at a risk to produce these health effects.   
 
 
2.11  Assessment of the burden of disease using the WHO spreadsheets 
The expected IQ reduction and cases of MMR that may result from BPb distribution were 
calculated using WHO spreadsheets and guidelines for burden of disease from lead 
exposure (WHO, 2003a, Prüss-Üstün et al., 2003a).  The spreadsheets are based on the 
(linear) relationship between IQ points lost and BPb from the meta-analysis by Schwartz 
(1994) (WHO, 2003a). For this purpose the WHO has given estimates of proportions or 
expected incidence rates of children who are at risk for various BPb lead intervals.  The 
spreadsheet calculates the number of children just above the MMR threshold of 70 IQ 
points who would drop into the MMR range due to lead-induced loss of IQ points.  The 
spreadsheet requires use of a regional adjustment ratio for MMR to account for variations 
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in the incidence of MMR from such causes as anaemia and meningitis.  For this study, a 
regional adjustment ratio of 2.0 was used (WHO, 2003a).   
 
 
The incidence of MMR from the first WHO spreadsheet was entered into the second WHO 
spreadsheet together with population data in order to estimate the DALYs attributed to 
childhood exposure to lead.  DALYs comprise of the sum of Years Lived with Disability 
(YLD) and Years of Life Lost (YLL) from a disease or health state. YLD, which represents 
the morbidity from a disease, are calculated by multiplying the duration of the disease in 
years with a disability weight. The disability weight is a value from zero to one that 
estimates the severity of the disease, where zero indicates perfect health and one would 
indicate a full year lost to death (Caravanos et al., 2014).   MMR due to lead has a 
disability weight of 0.361 (WHO, 2003b). 
 
 
2.12 Identification of risk factors for high blood lead  
Proportions and means were generated and compared using Mann-Whitney test and 
Kruskal Wallis tests at 5% level of significance. Quantile- quantile (Q-Q) plots of log 
transformed data were prepared to assess differences in distribution of BPb for some of the 
potential risk factors.   Multivariate logistic regression analysis was conducted to evaluate 
the relationship between the explanatory variables and high blood lead (BPb ≥ 5 µg/dl). 
Adjusted odds ratios (ORs) and their corresponding 95% confidence intervals were then 
calculated.  
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3.0 Results  
This chapter summarizes the major findings of the study, which include laboratory results 
on blood lead and concentrations of lead in various samples,  statistical analyses of  the 
laboratory results, and results on predicted BPb values,   assessment of the applicability of 
the IEUBK model, correlation of  measured and predicted BPb values to health effects,  
assessment of the burden of disease, and assessment of the  risk factors 
 
 
3.1 Socio-demographics 
There were 152 subjects between 1 to 6 years of age, with 82 male and 70 female. 
   
 
3.2 Lead in blood 
The raw data for BPb is presented in Table 10 in Appendix II.  The average BPb was 6.9 ± 
5.3 µg/dl, where 71.7% of the children had high BPb i.e. BPb ≥ 5 µg/dL and 22.8% had 
BPb ≥ 10 µg/dl.  However, it is important to note that because of the uncertainty in BPb 
measurements of 14.5% BPb values of 5 µg/dl may actually range from 4.3 to 5.7 µg/dl. 
Therefore, the uncertainty in BPb measurement may slightly affect the prevalence of high 
BPb.  The descriptive statistics for the BPb, without including the uncertainty, are 
presented in Table 5 below.  
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Table 5:  Descriptive statistics of blood lead 
Parameter Value (µg/dL) 
Range  2.0 – 50.4 
Arithmetic mean 6.9 ± 5.3 
Geometric mean 6.5 ± 10* 
25
th
 percentile 4 
75
th
 percentile  8 
95
th
 percentile 13 
Median 6 
BPb ≥ 5 µg/dl.    71.7% 
BPb ≥ 10 µg/dl.    22.8% 
* Geometric mean ± geometric standard deviation 
 
 
3.3  Lead from other sources 
3.3.1 Lead in paint 
The USEPA defines lead-based paint as hazardous if contains lead above a concentration 
of 90  mg/kg  (CPSC, 2008), whereas the limit for lead in paint in most countries is 600 
mg/kg (Clark et al., 2009). The concentrations of lead in fresh paint are presented in Table 
12 in the Appendix II.  It can be seen that the values have ranged from 1.1 mg/kg to 7139 
mg/kg, where 56 % of the samples were above 90 mg/kg while 37.5% were above 600 
mg/kg. 
 
 
From Table 13 in Appendix II it can also be seen that the concentrations of lead in paint 
chips from houses ranged from 0.62 mg/kg to 6458 mg/kg.  Only 2 of the 23 samples had 
hazardous amounts of lead.   
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3.3.2 Lead in toys 
It can be seen in Table 14 in Appendix II that lead content in toys ranged from 0.091 
mg/kg to 9.00 mg/kg, indicating that all the toys contained lead in amounts that were much 
lower than  the CPSC limit value of 100 mg/kg (CPSC, 2008). 
 
 
3.3.3 Lead in food and water 
Concentrations of lead in food are presented in Table 15 in Appendix II.  In summary, the 
values ranged from 0.01 mg/kg in chicken to 3.3 mg/kg in chips. These concentrations are 
much higher than those values published for Spain (10 µg/kg to 350 µg/kg) (Heard et al., 
1983, Cuadrado et al., 2000), Germany (18.7 µg/kg to 52 µg/kg) (Wilheim et al., 2003), 
Chile (below detection limit to 251 µg/kg) (Muñoz et al., 2005) and Nigeria 102.25 µg/kg 
to 125 µg/kg (Akinola and Ekiyoyo, 2006).  On the other hand, the concentrations of lead 
in food from Blantyre are of a similar order of magnitude to those published in Korea 
(below detection to 0.54 mg/kg) (Lee et al., 2006) and Mexico (<0.003–66.32 mg/kg) 
(García-Rico et al., 2007).  
 
 
All of the water samples contained lead in amounts that were below the detection limit of 
0.000018 mg/L (results not provided).  
 
 
3.3.4 Lead in house dust and soil  
Results of lead in soil and dust are presented in Table 16 in Appendix II.  The 
concentrations of lead in house dust ranged from 2.3 mg/kg to 265 mg/kg, with an outlying 
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figure of 17179 mg/kg.  Apart from the latter outlying figure, the concentrations of lead in 
house dust in most homes are much lower than the US limit of 400 mg/kg for lead in soil 
in playgrounds.  From the same table, it can also be seen that the concentration of lead in 
soil ranged from 1.5 mg/kg to 482 mg/kg, with only one sample of soil containing lead 
above the limit of 400 mg/kg.  Therefore, it can be concluded that in general the 
concentrations of lead in house dust and playground soil in many homes in Blantyre were 
very low.   
 
 
In addition, a paired student’s t test indicated that there is no significant difference between 
corresponding concentrations of lead in house dust and lead in the soil samples taken from 
yard on which the children often play.  Similarly, one factor Analysis of variance 
(ANOVA) indicated that there were no significant differences in lead concentration in 
samples of house dust and the corresponding soil samples taken from various health 
catchment areas.   
 
 
3.4  Food consumption rates 
Food consumption rates are provided in Table 17 in the Appendix II.  Results indicated 
within the table indicate that foods that are consumed by children in significant rates 
include: include the following:  Mealie meal or Msima (520.3 g/day), bread (31.35g/day), 
mangoes (86.78 g/day), green maize (34.82 g/day), rice (105.6 g/day), maize flour porridge 
(109.4 g/day), soya porridge (121.6 g/day), chicken (66.65g/day), chips (38.5 g/day),  
beans (30.88 g/day), and drinks such as Sobo (96.25g day) and freezes (68.83 L/day) .  Then 
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food items were also included within the table which were not consumed in significant 
rates 
 
 
3.5 Predictions by the IEUBK model and comparison with measured blood lead 
The IEUBK model is designed to predict BPb levels from exposure to lead from a limited 
number of external sources including food, water, air, soil and house dust due to the fact 
that the exposure rates from these external sources are possible to assess. For the same 
token, it is therefore not possible to use this model to predict BPb from external sources 
such as toys and paint as exposure rates to lead from these sources are not practically 
possible to assess. 
 
 
In the present study, as lead in air was not measured and also the concentrations for lead in 
water were below detection limit, it was only possible to use the lead levels assessed in 
food, soil and house dust. Using these latter values, in addition to the default and published 
values for availability of lead from these sources, it was possible for us to predict the BPb 
levels resulting from exposure to lead from the aforementioned three sources. For example, 
using the default bioavailability value for lead in food (50%) and a default bioavailability 
value for lead in soil (30%), the obtained predicted values of BPb ranged from 10.5 µg/dL 
to 39.2 µg/dL, with a geometric mean of 12.5 µg/dL, compared to the measured BPb 
values which ranged from 2.0 µg/dL to 50.4 µg/dL, with a geometric mean of 6.5 µg/dL 
(Table 18, Appendix II). The comparison of the geometric means of predicted BPb with 
the geometric means of observed BPb segregated by age of children is provided in Figure 
12 below.  
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It is important to note that the IEUBK model is designed to predict BPb values below 30 
µg/dL and is set calculate geometric means for populations.  Therefore, all BPb values 
above 30 µg/dL have been removed in the calculation of the averages for comparisons.  
Consequently, the skewness of the data brought by values above 30 µg/dL has been 
reduced. Furthermore, as the BPb values were still not normally distributed even after 
dropping BPb values above 30 µg/dL, geometric means were calculated to reduce effects 
of outliers.  The geometric mean, which is equivalent to log-normally transformed data, is 
less subject to distortion caused by positively skewed data, and is thus a better measure of 
central tendency of skewed data than the arithmetic mean (Olivier et al., 2008, Bland and 
Altman, 1996). 
 
 
 
Figure 12: Comparison of the geometric means predicted and mean observed BPb against 
age 
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The Pearson correlation coefficient of -0.07 between the predicted and measured BPb 
values, NSE of  -3.30, ME of -2.24, RMD of 88 and the students’ t-test have indicated poor 
agreement between these two values, bias in the model and that the measured mean was a 
better description than the values predicted by the model.  Subsequently, it could be said 
that there was significant difference between measured and predicted BPb values when a 
default bioavailability of 50% for lead in food and 30% for lead in soil were used, 
indicating that the predicted values were on average two-fold higher than the measured 
values.   
 
 
Furthermore, using the 95% agreement method, the averages of the measured and 
predicted BPb values were plotted against the differences between predicted and measured 
values for each individual is given in Figure 13 below.  The differences between predicted 
and measured values have a mean of 5.96 µg/dL and a standard deviation of 3.65.  
Therefore, as the 95% limits are 5.96 ± 1.96 x 3.65 (i.e. 13.1 and -1.11)  it can be 
concluded that for 95% of children, prediction by the IEUBK model would be between 
about 1 µg/dL less and about 13 µg/dL higher than measured values (Bland and Altman, 
2003).   Since the critical value for BPb in children is only 5 µg/dL, the model would tend 
to over-predict most BPb values when 50% dietary lead bioavailability is used.  This over-
prediction is consistent with the results displayed in Figure 12 above.   
 
 
The over-prediction is also shown by the sensitivity analysis of the IEUBK model as a 
diagnostic tool, where it could predict all children to have BPb above 5 µg/dL (100%), and 
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as yet the measured values could show that only 71.7% of children had BPb above  5 
µg/dL (false positives 28.3%).   
 
 
 
Figure 13:  A plot of the average of the measured and predicted BPb against the differences 
between predicted and measured BPb values (for 50% food bioavailability) 
 
 
 
On the other hand, using a bioavailability of 31% for lead in food obtained from the 
literature and a default bioavailability of 30% for lead in soil, the predicted BPb values 
obtained have ranged from 6.8 to 33.9 µg/dl, with geometric mean of 8.30 µg/dl, once 
again compared to measured BPb values which ranged from 2.0 µg/dL to 50.4 µg/dL, with 
a geometric mean of 6.5 µg/dL.  These predicted and measured values are presented in 
Table 17 in Appendix II.  The comparison of the geometric means of predicted BPb with 
the geometric means of observed BPb segregated by age of children is provided in Figure 
14 below. 
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Figure 14:  Comparison of the geometric means predicted and mean observed blood lead 
against age 
 
 
In this instance, the Pearson correlation of 0.079 between the predicted and measured BPb 
values, an NSE of -0.3, and a paired t-test values have indicated poor agreement between 
the predicted and measured BPb values. On the other hand, an RMD value of 25.7 
indicated slight bias in the model and an ME value of +0.49 has shown that the predicted 
values are better indicators of BPb levels than the mean of measured BPb.  As such, the 
ME and RMD values have provided an acceptable agreement between the two sets of 
values, where the predicted values were on average only 1.3-fold higher than the measured 
BPb values.  
 
 
For the 95% agreement method, a plot of the average of the measured and predicted BPb 
against the differences between predicted and measured values for each individual (for 
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31% dietary lead bioavailability) is provided in Figure 15 below.  The differences between 
predicted and measured values have a mean of 1.74 µg/dL and a standard deviation of 
3.44.  Therefore, as the 95% limits are 1.74 ± 1.96 x 3.44 (i.e. -5.0 and 8.48)  it can be 
concluded that for 95% of children, prediction by the IEUBK model would be between 
about -5 µg/dL less and about 8 µg/dL higher than measured values.   Predictions of 5 
µg/dL less or 8 µg/dL higher than measured values may result in misallocation of a child’s 
BPb, especially since the critical value for BPb in children is only 5 µg/dL.   Nevertheless, 
there is much better agreement between predicted and measured BPb than in the case when 
50% dietary lead bioavailability was used, which indicates that the value of bioavailability 
used in the model can have a significant impact on the level of agreement between 
predicted and measured BPb values.   
 
 
 
Figure 15:  A plot of the average of the measured and predicted BPb against the differences 
between predicted and measured BPb values (for 31% dietary lead bioavailability) 
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Furthermore, as was the case when 50% dietary lead bioavailability was used, the IEUBK 
model could correctly predict the BPb of all children that had BPb above 5 µg/dL, with 
false positive results for 28.3% of the children that had BPb below 5 µg/dL. 
 
 
3.6 Assessment of the contribution of soil and food to measured blood lead 
The IEUBK was also utilised to assess separately the contribution of each food and soil as 
external sources of exposure to the measured BPb values. For the assessment of the former, 
the dietary intakes and the bioavailability values of 50% or 31% of lead in food were 
utilised to obtain the predicted BPb values as well as the percentage contribution of the 
dietary lead intake to the measured BPb values (Table 19, Appendix II). Although the 
concentration of lead in food was constant, food consumption was different depending on 
the amount of food consumed per child depending on age.  When either 50% or 31% 
bioavailability of lead from total food consumed per child was calculated, different % 
contribution was estimated for each % lead bioavailability.  However, although a quotient 
of 1.6 (i.e. 50%/30%) (Table 19) would have been expected, different values of this 
quotient could be observed per child.  A quotient of 1.6 would ideally be expected if 
uptake was linear function of concentration or bioavailability of lead.  Contrary to this 
expectation, lead absorption has been observed to occur through saturable and non-
saturable components that resulted in a non-linear function of total uptake. Consequently, 
BPb concentrations did not increase proportionately with dose (Aungst et al., 1981), and 
according to the USEPA, “there are significant non-linearities in the empirical relationship 
between lead intake and observed BPb that can be attributed to saturation of lead uptake 
from the gut as well as the nonlinear binding in red cells” (USEPA, 1994b). Furthermore, 
renal lead clearance and BPb clearance resulting from distribution of lead to other 
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compartments (tissues, bone, teeth, hair, and finger and toe nails are not linearly related to 
the magnitude of the dose (Aungst et al., 1981, Rabinowitz et al., 1976).  It is not 
surprising, therefore, that the quotient of % contribution for 50% vs 31% in Table 19 is not 
a single value of 1.6 but ranges from 1.4 to 1.7, with an average of 1.48. 
 
 
It can also be seen in Table 19 that the dietary contribution to total BPb ranged from 58% 
to 610% (for 50% bioavailability) and from 31% to 410% (for 31 % bioavailability). 
Therefore, there were many instances of overestimation for both bioavailabilities, arising 
from the inaccuracies in the food consumption rates as reported by parents.  Nevertheless, 
despite of the inaccuracies in the food consumption rates it can be concluded that food is a 
significant contributor of BPb.   
 
 
For the assessment of contribution of soil as an external source, a similar exercise was 
followed and the results are presented in Table 20, Appendix II. In this case, a default 
bioavailability value of 30% was applied and the contribution of lead intake from this 
source was calculated to be ranging from 1% to 23% with an outlier of 582%. From the 
corresponding predicted BPb values presented in the same table, it can be seen that the 
mean predicted BPb values were much lower than the measured values which ranged from 
0.1 µg/dL to 3.0 µg/dL with a mean of 0.5 µg/dL, and subsequently were much lower than 
the measured BPb values, and thus translating to an average of 1.4-fold lower than the 
measured BPb values.  
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3.7 Relating of BPb to adverse health effects  
Adverse health effects that may result from exposure to lead were determined by relating 
the relevant health effects to the percentage of children above the relevant threshold values 
presented earlier in Table 2.  The results are presented in Table 5 where it can be seen that 
71.7% of children had BPb above 5 μg/dL, indicating the possibility that they may be at 
risk of suffering from IQ reduction. On the other hand, none of the children had BPb levels 
above 60 μg/dL, and hence the risk of suffering from lead-induced anaemia and gastro-
intestinal effects amounted to zero. 
 
 
Table 6:  Adverse health effects that may arise from exposure to lead among children in 
Blantyre 
 
Adverse effect BPb threshold (μg/dL) % at risk 
IQ reduction ≤ 5  71.7 
Anaemia ≤ 60 0 
Gastro intestinal effects ≤ 70 0 
 
 
3.8 Estimation of burden of disease 
As discussed earlier in Section 1.10.3.2.1, children with pre-existing conditions of low IQ 
are at a risk of suffering from MMR.  Consequently, through the use of WHO burden of 
disease spreadsheets and guidelines for burden of disease from lead exposure (WHO, 
2003a, Prüss-Üstün et al., 2003a), it could be determined that the distribution of BPb 
among children in Blantyre would result in 8.38 cases of MMR per 1000 children between  
1 and 4 years  old.   A similar estimate could not be performed for children aged between 5 
and 6 years due to lack of population data.   
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Using the prevalence rates of MMR, the DALYs for children aged 0-4 years attributable to 
lead-induced MMR were calculated to be 7314 DALYs.  Because MMR is not inherently 
fatal, the analysis does not consider YLL but only YLD   Therefore, the DALY 
calculations represent only the morbidity and does not incorporate any premature mortality 
associated with lead exposure.  As a way of interpretation, ‘a child who develops MMR 
from lead exposure at birth and has a life expectancy of 80 years is said to have lived 28.9 
YLDs (80 years x 0.361 (the disability weight for MMR)’) (Caravanos et al., 2014).  As 
expected, the burden of MMR of 7,314 estimated in the present study for a small city such 
as Blantyre is much lower than the national burden of MMR of about 44,000 attributed to 
lead in South Africa (Norman et al., 2007).  
 
 
3.9 Risk factors for high blood lead  
The descriptions of the participants in relation to the (potential) risk factors are presented 
in Table 7 below. The risk factors that have been considered in the present study included 
age, sex, living in a painted house, residential/catchment area, mouthing behavior, use of 
pottery, use of the toys. As indicted in this table, there were more male than female 
children.  In addition, the number of subjects was not equally distributed within the same 
catchment area and that most of the parents/guardians did not know the use of toys, pottery 
and mouthing behaviour of their children 
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Table 7:  Description of participants with respect to the risk factors 
 
Characteristics Number of children (%) 
(N=152) 
Age (mean ± SD)
a
 4.07 ± 1.59 
Sex  
Male  
Female 
82  (53.9%) 
70  (46.1%) 
Living in painted house  
No (Ref) 
Yes 
Not reported 
55  (36.2%) 
37  (24.3%) 
60  (39.5%) 
Area of residence  
Chilomoni 
Ndirande 
Bangwe 
Limbe 
Zingwangwa 
Machinjiri 
29  (19.1%) 
28  (18.4%) 
18  (11.8%) 
7  (4.61%) 
31  (20.4%) 
39  (25.7%) 
Guardian observing mouthing behaviour of 
child 
 
No (Ref) 
Yes 
Don’t know 
21  (31.8%) 
64  (41.3%) 
67  (44.1%) 
Guardian observing use of pottery by child  
No (Ref) 
Yes 
Don’t know 
66  (43.4%) 
19  (12.5%) 
67  (44.1%) 
Guardian observing use of toys by child  
No (Ref) 
Yes 
Was not sure 
44  (28.9%) 
41 (27.0% 
67 (44.1%) 
a 
 The children were aged 1 to 6 years. Ref = Reference category 
 
 
The prevalence of high BPb was calculated in relation to different risk factors (Table 8), 
where it can be seen that there were differences in prevalence values of high BPb in 
relation to residence or catchment areas, especially for the area of Chilomoni which was 
substantially difference from the other areas. However, it is important to note that although 
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Machinjiri in Table 8 has the least prevalence of high BPb, it had a number of children 
with BPb values above 20 μg/dL. 
 
 
Table 8: Prevalence of high BPb based on different risk factors 
 
Category Prevalence (%) 95% CI 
Age  category (years)   
1-3 
4-6 
72.6 62.9 – 82.3 
70.6 59.6 – 81.6 
Sex   
Male 
Female 
69.5 59.4 - 79.6 
74.2   63.8 – 84.6 
Living in painted house
a
   
No 
Yes 
69.1 56.6 – 81.6 
78.4 64.7 – 92.0 
Area of residence   
Machinjiri 
Zingwangwa 
Ndirande 
Limbe 
Bangwe 
Chilomoni   
64.1 48.7– 79.4 
77.4 62.3– 92.5 
67.9 50.1 – 85.6 
71.4 35.0 – 108 
66.7 44.1 – 89.3 
82.8 68.7 – 96.9 
Guardian observing mouthing behaviour of 
child
a
 
  
No 
Yes 
66.7 45.7 – 87.6 
73.4 62.4 – 84.5 
Guardian observing use of pottery by child
a
   
No 
Yes 
72.7 61.7 – 83.7 
68.4 46.6 – 90.2 
Guardian observing use of toys by child   
No 
Yes 
77.3 64.5 – 90.0 
65.9 50.9 – 80.8 
a
 the proportions excludes the missing values. 
 
In addition, differences could also be seen when the total number of BPb levels were 
plotted against the area of residential/catchment area using Q-Q plots (Figure 16).  Since 
the plots were not identical, it can be said that each residential/catchment area had its 
unique distribution of BPb levels.  
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Figure 16:  Inverse normal distribution Q-Q plot of BPb for children in the various 
residential/catchment (A Machinjiri, B Limbe, C Zingwangwa, D Bangwe, E Ndirande and 
F Chilomoni)  
 
 
3.9.1  Bivariate and multivariate logistic regression 
The differences in mean BPb levels in the previous section within different 
residential/catchment areas were further analysed, in addition to other risk factors, using 
bivariate and multivariate logistic regression to establish associations between these 
variables (Tables 9 and 10).   
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Table 9:  Mean values for high BPb for each characteristic and results of Wilcoxon rank-
sum/Kruskal-Wallis test for significant differences within each characteristic 
Characteristic Mean high BPb 
(µg/dL) 
p-value 
Age  category (years)  0.978 
1-3 
4-6 
8.54 (±6.25)  
8.13 (±4.97)  
Sex  0.559 
Male 
Female 
7.87 (± 2.98)  
8.88 (± 7.65)  
Living in painted house  0.797 
No 
Yes 
7.90 (±3.60)  
7.41 (± 2.01)  
Area of residence  0.013 
Machinjiri 
Zingwangwa 
Ndirande 
Limbe 
Bangwe 
Chilomoni   
10.2 (±6.77)  
9.38 (±9.14)  
6.51 (±1.77)  
5.60 (±0.547)  
8.00 (±3.10)  
7.58 (±1.98)  
Guardian observing mouthing behaviour of 
child 
 0.733 
No 
Yes 
8.26 (±4.81)  
7.50 (±2.43)  
Guardian observing use of pottery by child  0.893 
No 
Yes 
7.65 (±3.20)    
7.77 (± 2.83)  
Guardian observing use of toys by child  0.318 
 No 7.80 (±3.85) 
Yes 7.52 (±1.85) 
 
 
 
 
 
Results presented in Table 8 indicate that indeed there were statistically significant 
differences in relation to residence/catchment areas, with a p value of 0.013, while no such 
significant differences could be obtained between mean BPb and the other risk factors 
considered.  On the other hand, because of the very wide confidence intervals, it could not 
be determined from Table 10 whether  or not, sex, age, living in a painted house and 
mouthing behaviour as well as residential/catchment areas are risk factors for high BPb.   
Nevertheless, as the p-value for area of Chilomoni was the only one having p-value of 
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0.049 (< 0.05), it should then be considered that some areas but not all residential/ 
catchment areas may be risk factors for high BPb.   
 
 
Table 10:  Results for multivariate analysis 
 Odds ratio 95% CI p-value 
Age (mean years)  1.10 0.815 – 1.50 0.52 
Sex    
Male 
Female 
1.00 -  
1.17 0.9 -1.61 0.9 
Living in painted house    
No 
Yes 
1.00 - - 
2.06 0.66 – 6.52 0.22 
Area of residence    
Machinjiri 
Zingwangwa 
Ndirande 
Limbe 
Bangwe  
Chilomoni  
1.00 - - 
2.34 0.52 -  10.5 0.26 
2.76 0.571 - 13.3 1.26 
3.83 0.284 - 51.5 0.312 
0.304 0.0200 - 4.63 0.392 
6.94 1.01 -  47.6 0.049 
Mouthing behaviour    
No 
Yes 
1.00 - - 
2.04 0.506 - 8.24 0.316 
Use of pottery    
No 
Yes 
1.00 - - 
0.725 0.1979 - 2.65 0.627 
Use of toys    
No 
yes 
1.00 - - 
0.346 0.104 - 1.14 0.083 
 
 
 
 
4.0 Discussion  
This chapter discusses the results on levels and sources of exposure to lead, the risk factors 
for high blood lead, the applicability of the IEUBK model in Blantyre, potential health 
effects and  potential burden of diseases that are associated with the levels of exposure to 
lead among children in Blantyre, study limitations as well as  recommendations that can 
be drawn from the study.  
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This present study aimed at assessing levels of exposure to lead, sources of lead and the 
risk factors for high BPb, the associated risks of suffering from adverse health effects, and 
the applicability of the IEUBK model for predicting BPb among children in Blantyre.  
 
 
The assessment of the levels of BPb in this cross sectional study has indicated that indeed 
there were high levels of exposure to lead among children in Blantyre, where 71.7% of 
children had BPb ≥ 5 µg/dL, and 23 % had BPb ≥ 10 µg/dL.  Similar investigations that 
were conducted in other countries in the region have also shown high levels of exposure to 
lead among children. These have included Botswana, where 31% of the children had BPb 
levels ≥ 10 µg/dL (Mbongwe et al., 2005) and South Africa, where 78% of children having 
BPb ≥ 10 µg/dL BPb  (Mathee et al., 2002). However, it needs to be pointed out that these 
two studies were conducted soon after the introduction of regulations on leaded petrol in 
these countries, whereas the present study has been conducted about ten years after the 
introduction of these regulations. Other investigations conducted in countries outside the 
region have also indicated that the levels of BPb found in the present study for children in 
Blantyre were much higher than those reported for example for China,  where only 1.32% 
of children had BPb above 5 µg/dL (Li et al., 2014a).  The results obtained in the present 
study had therefore warranted us to investigate further on the sources of lead that may have 
contributed to such high levels of BPb in Blantyre.  Subsequently, a number of possible 
sources of lead were investigated including food, soil and house dust, paint, toys and water. 
 
 
Food was the first source to be investigated, where the present study could ascertain that 
food is the major contributor to the high BPb in children.  Investigations in the literature 
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have also shown that food has been the major contributor to BPb in China (83.4%) (Li et 
al., 2016) and Belgium (over 75%) (Cornelis et al., 2006).  Present results and those 
presented in the literature thus reiterate the importance of food as a major source of lead of 
BPb and hence it is recommended further investigations to elucidate the origins of high 
lead contained in food.  Dietary lead originates from environmental sources such as soil, 
water and air, as well as food processing, food handling, and food packaging. According to 
the CODEX Alimentarius, “sources of lead from food processing include lead paint and 
lead-containing equipment, such as piping and lead-soldered machinery, whereas sources 
from packaging include lead-soldered cans coloured plastic bags and wrapping papers, 
cardboard containers lead foil capsules on wine bottles, and lead-glazed ceramic, lead 
crystal and lead-containing metal vessels used for packaging or storing food” (JECFA, 
2004).   There is need for a systematic investigation of the contribution of these sources to 
dietary lead.   
 
 
In the present study soil and house dust were shown to be minor contributors (11.2%). 
These results were in agreement with those  reported for China (15%) (Li et al., 2016) but 
in disagreement with those reported for Australia (54%) (Zheng et al., 2013).  In contrast, 
water samples in the present study have been shown to contain undetectable amounts of 
lead, and hence it could be said that contribution of water to BPb was minimal. Our results 
were, however, not in agreement with those reported for the USA (Edwards et al., 2009) 
and Germany (Fertmann et al., 2004). 
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The contributions of the sources of lead (food, soil and house dust) to BPb reported in the 
preceding paragraphs were estimated through the use of the IEUBK model.  However, 
prior to the use of this model for these determinations, it had to be evaluated, by comparing 
predicted BPb with measured BPb.  The comparisons showed that this model may be used 
provided that the bioavailability values for lead from different sources are available as well 
as the food consumption rates are provided for Malawi.  Similar comparisons in other 
countries such as China (Li et al., 2016), Kazakhstan (Rasmuson et al., 2012), Belgium 
(Cornelis et al., 2006) and Mexico (Gersberg et al., 1997) have also shown that the model 
may be applied for prediction of BPb in children in the respective countries.   
 
 
Other sources of lead were also investigated including toys and paint chips from the 
residences of participants, where both of these samples were found to contain very low 
levels of lead.  These results are contrary to those reported in the literature for toys for 
India (Kumar and Pastore, 2007), Nigeria (Omolaoye et al., 2010), USA (Greenway and 
Gerstenberger, 2010) and Turkey (Aliyev et al., 2011) and for paint chips for Nigeria 
(Nduka et al., 2008).  In contrast to toys and paint chips, our investigation on lead in fresh 
paint has shown that 56% of the samples of fresh paint contained high levels of lead, which 
is in agreement with   studies conducted in other countries including China, India, 
Malaysia, Brazil, Singapore and Nigeria (Clark et al., 2006, Clark et al., 2009). 
 
 
The high levels of exposure to lead among children in Blantyre from numerous sources has 
warranted further investigation on the risk factors for high BPb, which are thought to affect 
exposure to lead from the previously identified sources of lead.  The risk factors which 
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were investigated in the present study have included age, sex, living in a painted house, 
residential/catchment area, mouthing behavior, use of pottery and use of the toys. Among 
these potential risk factors, the residential/catchment area of Chilomoni was found to be a 
significant risk factor for high BPb.  Similar investigations have shown that residential area 
is a risk factor for high BPb, often as a result of differences in (industrial and traffic) 
sources (Chen et al., 2012).  However, as Chilomoni is not a heavy industry area (as per 
discussion of page 82), industrial sources are not likely to be the source of lead in 
Chilomoni.  Usually contribution of lead from these industrial sources will manifest itself 
with a high content of lead in soil.  However, one factor ANOVA in Section 3.3.4 indicated 
that there were no significant differences in lead concentration in samples of house dust 
and the corresponding soil samples taken from various health catchment areas.  It can be 
concluded that as yet, sources could not be identified that may explain why Chilomoni 
residential/catchment area is to be a significant risk factor for high BPb. 
  
 
On the other hand, due to very wide confidence intervals it could not be determined 
whether sex, age, living in a painted house and mouthing behavior were significant risk 
factors for high BPb in Blantyre.  Nevertheless, in the literature age (Menezes-Filho et al., 
2011), sex (Li et al., 2014b), living in a painted house (Schwartz and Levin, 1991), and 
mouthing behavior (Kranz et al., 2004) have been reported to be significant risk factors for 
high BPb.   Therefore, there is need for further investigations on the roles of these potential 
risk factors to lead exposure in Blantyre using studies with greater samples (statistical 
power).  
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The establishment of high BPb as well as the main sources of exposure and risk factors has 
enabled us to assess the potential health effects that are likely to result from these 
exposures.  In this regard, the present study has ascertained that 71.7% of children were at 
risk of suffering from IQ reduction, which was already proven in the literature by many 
investigations  (Nevin, 2000, Schwartz, 1994).  Furthermore, the present study has shown 
that the children who are at risk to develop IQ reduction, an incident rate of 8.38 children 
out of 1000 between the ages of 1 and 4, will suffer from MMR.  This estimated incidence 
rate of MMR for Blantyre  is about 40-fold higher than those reported for Poland 
(Jarosińska et al., 2006), and about 9-fold higher than those reported for South Africa in 
2007 (Norman et al., 2007) and about 1.4-fold higher than those reported for those who 
live near toxic waste sites in low and middle income countries (Chatham-Stephens et al., 
2014).  Lead-induced IQ reduction and MMR in Blantyre are additional impediments to 
early stimulation and learning in a population where 27% of under-five children are 
underweight and about 50% are stunted (Madise and Mpoma, 1997).  Therefore, based on 
our results and those reported in the literature it is imperative that measures are taken to 
reduce the levels of exposure to lead in children in Blantyre. 
 
 
4.1 Limitations of the study 
The present cross-sectional study was subject to number of limitations, including use of a 
cross-sectional study design, use of a modest sample size, lack of (national) food 
consumption data, lack of air lead measurements and use of default input data in the 
IEUBK model for some of the parameters.     
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In its conceptual design, a cross-sectional study only captures a snapshot of exposure 
levels, on the assumption that levels of exposure to each individual remain constant with 
time.  Contrary to this assumption, however, levels of lead in dust, soil and food, may vary 
with time, and thereby affecting the cumulative lead in blood.   These variations may have 
significantly contributed to the poor agreement between predicted and measured BPb 
values. In contrast to cross-sectional studies, a longitudinal study design captures the 
variations in levels exposure.  Therefore, the IEUBK model could be more effectively 
evaluated using longitudinal studies that measure lead in the same participants and their 
environments periodically over time. However, longitudinal studies are much more costly 
than cross-sectional studies. 
 
 
The use of a modest sample size in the study also placed a limitation on the study.  This 
limitation was imposed by the huge costs of laboratory analyses of a large number of 
samples. In this study, a sample size of 152 participants is only a very small proportion of 
the entire population of children in Blantyre, and therefore limits the generalizability of the 
results to the whole population.  In addition, the sample size used in the study was not very 
adequate for the multivariate logistic modelling for the identification of the risk factors.  In 
this regard, use of a modest sample size may have resulted in the lack of firm associations 
between BPb and some risk factors as well as the wide confidence intervals for the odds 
ratios.  Use of a small sample size was exacerbated by missing data for some of the risk 
factors.   
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The study was also impacted by a high refusal or non-participation rate that may have 
resulted in aselection bias.  Refusal to participate in a study can be influenced by age, 
levels of education, level of income, marital status (Vrijheid et al., 2009, DeMaio, 1980, 
Keeter et al., 2000) and other factors.  Non-participation will especially introduce a 
selection bias in cases where refusal to participate is determined by a certain socio-
economic factor that is correlated with the attribute under consideration. This study had a 
high refusal rate probably because most respondents were not aware of the issue of lead 
poisoning.  Therefore, future risk assessments of lead in Malawi require more awareness of 
the issue of lead poisoning in order to reduce refusal rates.    
 
 
Lack of (national) food consumption data was also a great limitation in the study.  
Assessment of food intake would require a study on its own, covering a long period of time 
and involving thousands of participants.  Consequently, lack of food consumption data 
resulted in the poor agreement between predicted and measured BPb values.   
 
 
The study was conducted without measuring concentrations of lead in air, on the 
assumption that banning of leaded petrol has reduced its concentrations in air to negligible 
levels (Thomas et al., 1999).  This may not exclude the possibility that there may still be 
some industries that may use lead and therefore such investigations may be warranted in 
the future.   
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Finally, the use of default input data in the IEUBK model may have resulted in the poor 
agreement between predicted and measured BPb values.   The default parameters that were 
used in the study for bioavailabilities were obtained from studies in America and Europe, 
and therefore may not be appropriate for all children and for every site-specific application.  
Bioavailability is known to be affected by nutritional status of the subjects, and has also 
been shown to depend on the food matrix (Peijnenburg and Jager, 2003).  Therefore, 
prediction of BPb using biokinetic models such as the IEUBK model should ideally be 
conducted using site-specific bioavailabilities.    
 
 
5.0 Conclusion 
This chapter presents the main theoretical and policy implications, conclusions and 
recommendations that can be drawn from the study.   
 
 
Exposure to lead and related health effects 
The present study sought to assess levels of exposure to lead among children in Blantyre 
city, the sources and the risk factors for exposure.  The study has established that a 
substantial proportion of children in Blantyre are exposed to levels of lead that are 
detrimental to their health.  The study could also establish that food is a significant 
contributor of lead and that the residential/catchment area of Chilomoni is a risk factor for 
lead.  Consequently, from the finding of the present study it can recommended further 
studies should be undertaken to determine the origin of lead in food and methods for 
reducing it. Further studies are also recommended to establish the sources for high 
exposure to lead in Chilomoni.  
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Applicability of the IEUBK model to children in Blantyre  
The present study has also established that the IEUBK model may be applied in Malawi.  
However, better results could be obtained by use of national food consumption data and 
site-specific bioavailability values. Therefore, there is need to acquire accurate (national) 
food consumption data and other site-specific data for future risk assessments 
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7.0 Appendices 
7.1 Appendix 1:  Tool and aids used in the risk assessment 
 
The lead risk assessment questionnaire 
Date: 
Child’s code number: 
1 How long has the child stayed at this address? 
  less than 6 months   More than 1 year   More than 2 years  more than 3 years   
More than 4 years  more than 4 years  more than 5 years 
  
2 What is the previous address? 
 
3a Does the child spend time at: 
Day care   Baby sitter   Preschool   Primary school?   
b What is the name of the school, day care etc? 
  
c How many hours does he spend at school? 
  3 hrs  4 hrs  5 hrs  6 hrs  7 hrs  8 rs  other 
4 Please list the parents’ occupation and hobbies 
 Mother 
 
 Father  
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5 Is the house painted?   Yes     No 
If the house is painted, what are the colours? 
6 If you have lived in another house in the past 6 months, was the house painted? 
    Yes   No 
If yes, what were the colours? 
 
7 How far is the house from the main road where cars pass frequently? 
100 m   500m     1000m    more than 1000m   Other  
8 Has the child been observed eating/ mouthing non-food items?   
  
Yes            No 
 
9 If the answer to question 8 is yes, what does the child put in his mouth? 
      Hands                     Toys     Dirt   Paint chips  others 
 
10 If the answer to question 8 is yes, how often does the child put items to his/her 
mouth? 
      Rarely      Sometimes    Often 
 
11 Does the child use a pacifier?    Yes    No 
 
12 Is there loose paint on the walls inside the house or on the ceiling?    Yes    No 
 
13 Do you use pottery for preparing food or eating?     Yes    No 
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14 In the house, where does your child usually play? 
   In the bed room 
   In the sitting room 
  In the kitchen 
   Other 
 
15 Outside of the house, where does your child usually play? 
 
16 Does the child play more in the house or outside? 
  More in the house 
  More outside 
  Equally in the house as outside 
17 Does the child wear jewelry?    Yes   No 
 
18 Does the child eat imported candy?    Yes   No 
 
19 Does the child consume canned foods and drinks? 
   Often   Rarely  Never   
 
20 How often does the family use candles? 
  Very often  Often     Rarely     Never 
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Food frequency questionnaire (ffq) 
 
Date:        Child code number 
      
This questionnaire will give us information about your child’s eating habits. There are no 
“right” or “wrong” answers.  We want to know how often the child ate certain foods. For 
each of the foods listed, please indicate how many servings per week the child usually ate 
in the past month. (If you ate a food less than once a week, write a “0” in the space 
provided.  Where indicated, check whether your servings are large, small, or about average 
in size. 
 
 
1 Which meals does the child skip almost on a daily basis? 
 
 
 
 
 
2 Does the school that the child attends have a school feeding programme? 
 Yes    No 
 
3 If the answer to question 2 is yes, what foods are given to your child? 
 
 
 
Breakfast 1 
Lunch 2 
Evening meal 3 
None 4 
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4  Does the child ever eat outside the home e.g. at fast food shops such as Nandos etc? 
 
YES 1 
NO 0 
 
5 If the answer to question 4 is YES, in an average month how often do you eat at the 
following places?  
 
 Frequency of visits 
 Times/week Times/month Rarely/never 
Nandos    
Ali Baba    
KFC    
Kips     
Other restaurants/takeaways    
(Quarters from tuck shop)    
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
Cereals, grains, cereal 
products 
           
Nsima yaufa mgaiwa 
(normal flour) 
  101         
Nsima  yaufa refined 
(fine flour) 
  102         
Nsima yaufa madeya 
(bran flour) 
  103         
Nsima ya mawere 
(millet) 
  104         
Nsima ya mapira 
(sorghum) 
  105         
Green maize   106         
Rice   107         
Pearl millet (mchewere)   108         
Cake   109         
Bread   110         
Buns, scones   111         
Biscuits   112         
Spaghetti, macaroni, 
pasta 
  113         
Breakfast cereal   114         
Infant feeding cereals   115         
Mandazi , doughnut    116         
Samosa    117         
Maize porridge stiff     118         
Maize porridge soft   119         
Oats   120         
Popcorn   121         
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
Kamba puffs            
Other (specify)   123         
            
            
            
            
            
            
Roots and tubers, 
plantain 
           
Cassava tubers   201         
Msima ya condole 
(Cassava flour) 
  202         
White sweet potato   203         
Orange sweet potato   204         
Irish potato (baked)   205         
Irish potato (boiled)   206         
Irish potato (Mashed )   207         
Irish potato (Roasted)   208         
Chips   209         
Potato crisps   210         
Plantain, cooking 
banana 
  211         
Cocoyam (masimbi )   212         
Other (specify)   213         
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
            
            
Pulses            
Bean, white   301         
Bean, brown   302         
Pigeon pea (nandolo )   303         
Groundnut   304         
Groundnut flour 
(nsinjilo) 
  305         
Soya bean flour   306         
Ground bean (nzama)   307         
Cowpea (khobwe )   308         
Other (specify)   309         
            
            
            
            
Vegetables            
Cabbage   401         
Tanaposi    402         
Rape            
Nkhwani   403         
Chinese cabbage   404         
Other cultivated green 
leafy vegetables 
  405         
Gathered wild green 
leaves 
  406         
Tomato   407         
Cucumber   408         
Pumpkin   409         
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
Okra / Therere   410         
Carrots   411         
Tinned vegetables 
(specify): 
  412         
Mushrooms   413         
Other vegetables 
(specify): 
  414         
            
            
            
            
            
Meat, Fish, and 
Animal products 
           
Eggs fried   501         
Eggs Boiled/poached   502         
Eggs Scrambled   503         
Eggs omelet    504         
Dried fish   505         
Matemba             
Micheni             
Chambo             
kapenta            
usipa            
Fresh fish   506         
Matemba             
Micheni             
Chambo             
kapenta            
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
usipa            
Beef   507         
Goat meat   508         
Pork   509         
Chicken   510         
Mutton    511         
Sausage rolls   512         
Other poultry - guinea 
fowl, doves, etc. 
  513         
Small animal – rabbit, 
mice, etc. 
  514         
Tinned meat or fish   515         
Other (specify):            
            
            
Fruits            
Mango   601         
Banana   602         
Citrus – naartje, orange, 
etc. 
  603         
Pineapple   604         
Papaya   605         
Guava   606         
Avocado   607         
Watermelons            
Wild fruit (masau, 
mlambe, etc. ) 
  608         
            
Apple   609         
Other fruits (specify)   610         
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
            
            
            
            
            
Milk and Milk 
Products 
           
Fresh milk   701         
Powdered milk   702         
Chambiko - soured milk   703         
Yoghurt (sweetened)   704         
Yoghurt (fruit)   705         
Yoghurt plain   708         
Cheese   709         
Infant feeding formula 
(for bottle) 
  710         
Ice cream   711         
Ice lollies   712         
Other (specify)   713         
            
            
            
            
            
            
Sugar, Fats, and Oil            
Sugar   801         
Sugar Cane   802         
Cooking oil   803         
Butter   804         
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
Margarine   805         
Honey   806         
Syrup   807         
Jam    808         
Sweets    809         
Chocolates   810         
Other (specify)   811         
            
            
            
            
Beverages            
Tea with milk   901         
Tea without milk   902         
Coffee with milk    903         
Coffee without milk   904         
Cocoa with milk   905         
Cocoa without milk   906         
Squash (Sobo drink 
concentrate) 
  907         
Fruit juice (specify)   908         
Freezes (flavoured ice)   909         
Soft drinks (Coca-cola, 
Fanta, Sprite, etc.) 
  910         
Local sweet beer 
(thobwa ) 
  911         
Other (specify)   912         
            
            
Water            
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A.  
Food items (with FPM 
numbers 
B.  
Description of 
food item 
Tick 
for 
yes 
C item 
code 
D.  
Amount usually 
eaten 
No of spoons, 
cups etc 
Serving 
size 
1
Lg Av 
Sm 
E.  
Times 
Eaten 
every 
day 
F.  
Times 
Eaten 
every 
week 
.  
Eaten  
Occasionally 
H. 
Never 
eaten 
Grams 
(g) /day 
 
Comment 
Tap water   1001         
Bottled water   1002         
Well water   1003         
            
            
Miscellaneous            
            
            
            
            
1
Lg = Large; Av: Average; Sm = Small
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7.2 Appendix II: Concentrations of lead in various samples 
Table 11:  Measured blood lead 
Sample no  Age Sex BPb/ µg/dL(±14.5%) 
MC1 6 F 2 
MC2 6 M 2 
MC3 3 F 3 
MC5 4 F 10 
MC6 4 F 18 
MC7 1 F 3 
MC8 3 M 3 
MC9 3 F 5 
MC10  3 F 4 
MC11 2 M 20 
MC12 2 F 4 
MC13 6 M 5 
MC14 3 M 4 
MC15 6 M 8 
MC16 3 M 2 
MC 17 4 M 7 
MC 19 4 F 5 
MC20 3 M 9 
MC21 6 M 2 
MC22 2 M 4 
MC23 5 F 10 
MC29 4.9 M 8 
MC30 3.8 F 37 
MC38 6 M 10 
MC39 6 M 11 
MC24 3.8 M 6 
MC25 3 F 9 
MC26 4 M 10 
MC27 3 M 8 
MC28 5 M 10 
MC31 2 F 7 
MC 32 5 F 6 
MC35 4 M 6 
MC36 6 M 8 
MC37 2 M 7 
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Sample no  Age Sex BPb/ µg/dL(±14.5%) 
MC40 4 F 3 
MC41 6 F 3 
MC42 2 F 3 
MC43 4 M 22 
ZW 01 2 M 12 
Zw 02 2 M 10 
ZW 03 6 F 9 
ZW 04 6 M 8 
ZW 05 2 M 9 
ZW06 6 M 8 
ZW07 5 M 7 
ZW09 2 F 8 
ZW10 5 M 4 
ZW11 5 M 5 
ZW12 3 F 12 
ZW13 2 F 8 
ZW14 5 F 5 
ZW15 6 F 4 
ZW 16 2 F 4 
ZW17 2 F 7 
ZW 18 4 M 4 
ZW19 5 F 5 
ZW20 2 F 6 
ZW21 2 F 2 
ZW22 4 F 4 
ZW23 6 F 6 
ZW24 6 F 5 
ZW25 5 F 19 
ZW26 1.8 F 7 
ZW27 3 F 5 
ZW28 6 M 4 
ZW29 3 M 6 
ZW30 6 F 6 
ZW 31 3 M 5 
ZW32 4 F 52 
ND01 6 M 3 
ND02 2 M 4 
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Sample no  Age Sex BPb/ µg/dL(±14.5%) 
ND04 6 M 5 
ND05 4 M 5 
ND08 6 M 5 
ND07 3 M 5 
ND20 4 F 4 
ND28 6 M 3 
ND09 2 M 6 
ND10 4 F 7 
ND11 3 F 6 
ND12 2 F 8 
ND13 3 M 5 
ND14 3 M 4 
ND15 6 F 11.6 
ND16 5 M 4 
ND17 5 M 4 
ND18 5 M 4 
ND21 3 F 8 
ND22 2 F 6 
ND23 2 F 5 
ND24 5 M 5 
ND25 5 M 8 
ND26 2 F 8 
ND30 2 M 8 
ND31 6 M 7 
ND32 5 M 5 
ND33 6 F 3 
LM03 3 M 6 
LM04 3 F 4 
LM05 4 F 3 
LM06 6 F 6 
LM07 6 F 6 
LM08 3 M 5 
BN1 3 F 3 
BN2 6 F 15 
BN3 6 M 6 
BN4 1.7 M 10 
BN5 1.5 M 4 
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Sample no  Age Sex BPb/ µg/dL(±14.5%) 
BN6 5 M 13 
BN7 2.5 M 8 
BN8 6 M 6 
BN9 3 M 4 
BN10 5 M 4 
BN12 2 F 6 
BN13 2.3 M 4 
BN14 4 F 6 
BN16 3 M 7 
BN17 2 M 2 
BN18 6 M 7 
BN19 2.4 F 7 
CH 01 6 F 3 
CH02 2 M 5 
CH03 3 M 9 
CH04 4 M 4 
CH05 6 F 5 
CH07 6 F 6 
CH08 6 M 7 
CH09 6 F 5 
CH10 6 M 7 
CH11 4 F 8 
CH12 6 F 6 
CH13 3.9 M 10 
CH14 5 M 4 
CH15 5 M 7 
CH16 3 F 7 
CH17 3.5 F 6 
CH18 2 F 8 
CH19 3.9 M 7 
CH20 6 M 12 
CH21 4 F 8 
CH22 2 M 4 
CH23 3 M 7 
CH25 6 M 7 
CH26 6 M 8 
CH27 5 F 7 
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Sample no  Age Sex BPb/ µg/dL(±14.5%) 
CH28 5 F 13 
CH29 1.5 M 9 
CH30 6 F 8 
 
 
 
 
Table 12:  Lead in fresh domestic paint samples 
Paint  Samples Lead (mg/kg) ± 5% 
Plascon cream  170 
Plascon white 46 
Nuroc Bermuda blue  233 
Nuroc white  341 
Nuroc soft white  6372 
Nuroc black  1320 
Dulux gloss enamel red  7139 
Dulux black 1.1 
Dulux cream 2.0 
Rainbow high gloss black 2.7 
Rainbow high gloss white 6.0 
Olympic brilliant green 15 
Olympic white 9.3 
Olympic glossen cream  1996 
Olympic golden yellow  1074 
Olympic glossen cornflower  646 
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Table 13: Concentrations of lead in paint chips 
Sample no Lead concentration (mg/kg) 
ZW 1 3.5 
ZW 2 2.0 
ZW 12 161 
ZW16 6458 
ZW 17 44 
LM 05 89 
MC 9/10 2.4 
MC 10 2.4 
CH 8 2.3 
CH 9 71 
CH 21 1.0 
CH 23 22 
ND 3 2.9 
ND 6 4.0 
NdD7 2.4 
ND 8 1.7 
ND 17 0.86 
ND 21 0.65 
ND 22 2.0 
ND 23 0.62 
ND24/25 4.5 
ND 30/31 4.5 
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Table 14:  Concentrations of lead in toys 
Sample no  Concentration of lead (mg/kg) 
Toy 1 0.29 
Toy 2 0.47 
Toy 3 0.12 
Toy 4 0.90  
Toy 5 0.092 
Toy 6 0.091 
Toy 7 0.29 
Toy 8 0.10 
Toy 9 0.39 
Toy 10 5.1 
Toy 11 3.8 
Toy 12 3.4 
Toy 13 0.26 
Toy 14 0.16 
Toy 15 0.82 
Toy 16 0.91 
Toy 17 0.48 
Toy 18 4.4 
Toy 19 2.2 
Toy 20 9.0 
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Table 15:  Lead in various composite samples of food  
Food Sample Lead (mg/kg) ±5% 
Beans 0.076 
Green Maize 1.1 
Eggs 0.21 
Ground Nuts 0.059 
Popcorn 0.49 
Bread 0.40 
Irish potatoes 0.14 
Chips 3.3 
Dough nut 0.090 
Pap 0.65 
Mgaiwa porridge 0.040 
Buns 0.19 
Jiggles 0.27 
Kamba puffs 0.35 
Sobo Squash 0.019 
Thobwa 0.014 
Micheni 0.055 
Beef 0.15 
Rice  0.046 
Chambo 0.21 
Usipa  0.18 
Chinese cabbage 0.27 
Mpiru 0.35 
Mkhwani 0.49 
Rape 0.15 
Mangoes 0.058 
Sweet potatoes 0.12 
Bananas 0.047 
Chicken 0.010 
Cabbage 0.054 
Soya 0.16 
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Table 16:  Lead in dust and soil 
Sample No House dust (mg/kg)  ± 5 % Yard dust (mg/kg) ±5% 
MC 1 2.5 6.6 
MC2 2.3 5.0 
MC3 3.4 13 
MC 5/6 4.6 482 
MC7 11 11 
MC 8 2.7 11 
MC 11 3.0 20 
MC12 4.4 63 
MC13 26 13 
MC 14 5.3 6.9 
MC15 3.4 3.7 
MC 16 11 11 
MC17 4.7 7.9 
MC 18 - 5.8 
MC 19 - 5.8 
MC 20 10 5.7 
MC 21 - 4.4 
MC 22 - 4.4 
MC 23 10 4.9 
MC 24 3.4 9.4 
MC 25 3.4 5.2 
MC29 5.3 3.5 
MC38 3.4 3.7 
MC 26 22 28 
MC27 - 5.6 
MC 28 16 - 
MC 31 8.5 2.7 
MC 32 8.5 2.7 
MC35 2.7 4.3 
MC 36 2.7 4.3 
MC37 2.7 4.3 
MC 39 16 3.7 
MC 40 2.7 4.3 
MC 30 - 193 
MC 43 4.7 73 
MC 44 7.6 2.8 
BN4 4.0  
BN 12 2.5 1.5  
BN 13 2.7 2.0 
BN 14 4.1 2.7 
BN 16 21 11 
BN 17 6.8 8.0 
BN 18 5.6 5.0 
BN 19 14 5.5 
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CH05 8.8 8.1 
CH08 3.6 6.0 
CH04 - 6.1 
CH10 - 5.3 
CH11 3.4 5.2 
CH12 3.7 4.3 
CH13 27 6.5 
CH20 37 4.9 
CH24 - 11 
CH25 - 6.4 
CH01  4.9 5.5 
CH02 15 23 
CH03 48 16 
CH05 14 10 
CH07 6.5 5.8 
CH09 8.6 7.3 
CH14 7.4 6.6 
CH15 7.5 11 
CH16 2.6 4.6 
CH22 9.8 7.0 
CH24 - 29 
CH26 16 20 
Chilomoni Primary 12 - 
ND01 3.2 12 
ND02 3.2 12 
ND06 6.0 16 
ND08 7.6 6.5 
ND09 9.0 9.9 
ND10 9.0 - 
ND11 14 - 
ND13 7.0 9.6 
ND14 8.6 38 
ND15 - 7.9 
ND16 3.2 - 
ND17 - 34 
ND18 8.5 5.9 
ND19 23 4.7 
ND20 7.7 8.5 
ND21 8.9 10 
ND22 11 19 
ND23 6.5 12 
ND24 14 36 
ND25 - 36 
ND26 10 19 
ND28 23 8.8 
ND29 8.5 11 
ND30 22 12 
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ND31 22 12 
ND32 17 19 
ND33 48 5.4 
ND34 - 15 
ND35 - 4.7 
Makata Primary 14 - 
LM01 33 9.1 
LM02 15 9.1 
LM03 17 113 
LM04 8.8 10.1 
LM05 6.9 8.5 
LM06 99 6.5 
LM07 17179 39 
LM08 8.9 16 
ZW01 25 20 
ZW02 18 20 
ZW03 17 17 
ZW04 9.5 16 
ZW05 - 17 
ZW06 - 81 
ZW07 14 165 
ZW09 15 12 
ZW10 265 16 
ZW11 - 11 
ZW12 36 10 
ZW13 4.9 9.1 
ZW14 4.9 9.1 
ZW15 - 8.9 
ZW16 44 25 
ZW17 16 11 
ZW18 14 10 
ZW19 15 10 
ZW20 10 10 
ZW21 - 10 
ZW23 13 10 
ZW22 12 - 
ZW24 17 10 
ZW26 20 10 
ZW28 15 13 
ZW30 110 - 
ZW31 15 11 
ZW32 20  11 
ZW Primary school  5.4 3.8 
Naotcha Primary school 8.3 4.3 
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Table 17: Average food consumption data for children aged 1 to 6 years 
Food Item Average 
intake 
/week 
Average 
intake/day 
90th 
percentile/
week 
90th 
percentile/ 
day 
25th 
percentile/w
eek 
25th 
percentil
e/ day 
% 
consumi
ng 
Msima 3642 520.3 5754 822.0 1940 277.1 100 
Green maize 243.75 34.82 455.0 65.00 65 9.286 14.5 
Rice porridge 377.4 53.91 1257 179.6 0 0 23.6 
Rice  739.4 105.6 1267 181.0 387.3 55.32 32.7 
Bread 219.4 31.35 702.6 100.4 0 0 65.5 
Buns 80.5 11.50 189.0 27.00 0 0 34.5 
Biscuits 7.735 1.105 28.00 4.000 0 0 29.1 
Spaghetti 28.36 4.052 75.00 10.71 0 0 12.7 
Mandasi 81.93 11.70 192.5 27.50 0 0 21.8 
Samousa 40.91 5.844 50.00 7.142 0 0 14.5 
Soya poridge 850.9 121.6 1775 253.6 0 0 47.3 
Porridge 765.9 109.4 2359 337.0 0 0 56.4 
Pop corn 80.98 11.56 280.0 40.00 0 0 32.7 
Kamba 
puffs/jiggies 
132.6 18.94 470.0 67.14 0 0 30.9 
Sweet 
potatoes 
163.9 23.41 400.0 57.15 0 0 50.9 
Irish potatoes 168.3 24.04 456.0 65.15 0 0 36.4 
Chips 269.5 38.50 800.1 114.3 0 0 49 
Beans 216.2 30.88 797.4 113.9 0 0 43.6 
Cabbage 119.9 17.14 288.0 41.14 0 0 41.8 
Turnips 192.2 27.46 547.2 78.17 0 0 63.6 
Rape 130.2 18.60 441.6 63.09 0 0 49.1 
Pumpkin 
leaves 
156.9 22.42 312.0 44.57 0 0 58.2 
Chinese 
cabbage 
47.91 6.844 197.6 28.23 0 0 27.3 
Eggs 115.6 16.51 342.0 48.86 0 0 56.4 
Matemba 120.8 17.25 415.44 59.35 0 0 34.6 
Micheni 67.16 9.594 240.0 34.29 0 0 32.2 
Chambo 24.43 3.490 131.3 18.76 0 0 25.5 
Kapenta 58.06 8.295 202.8 28.97 0 0 30.9 
Usipa 103.9 14.86 320.0 45.71 0 0 41.8 
Beef 51.13 7.305 126.4 18.05 0 0 32.7 
Goat meat 35.28 5.040 68.00 9.714 0 0 23.6 
Pork 22.39 3.198 88.00 12.57 0 0 16.4 
Chicken 466.6 66.65 836.0 119.4 209 29.86 45.5 
Sausage 8.333 1.190 31.50 4.5 0 0 10.9 
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Food Item Average 
intake 
/week 
Average 
intake/day 
90th 
percentile/
week 
90th 
percentile/ 
day 
25th 
percentile/w
eek 
25th 
percentil
e/ day 
% 
consumi
ng 
Mango 607.5 86.78 1470 210 0 0 70.9 
Banana  75.00 10.71 230.0 32.86 0 0 34.5 
Fresh milk 147.7 21.10 500.0 71.43 0 0 14.5 
Tea with 
milk 
352.3 50.32 1400 200 0 0 29.1 
Tea w/o mik 1653 236.2 3000 428.6 750 107.1 76.6 
Sobo 673.8 96.25 2310 330 0 0 29.1 
Freezes 481.9 68.83 1365 195 0 0 61.8 
Fanta/coke 111.0 15.85 660 94.29 0 0 20 
Thobwa 218.1 31.16 500 71.43 0 0 36.4 
Water  8120 1160 9016 1288 7560 1080 100 
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Table 18:  Predicted BPb from all sources  
Sample 
no  
Age Measured BPb 
(µg/dL) 
BPb at 31% 
bioavailability for food 
lead (µg/dL) 
BPb at 50% bioavailability 
for food lead (µg/dL) 
MC1 6 2 8 12.2 
MC2 6 2 8 12.2 
MC3 3 3 7.9 11.8 
MC5 4 10 9 12 
MC6 4 18 9 12 
MC7 1 3 10.6 17.3 
MC8 3 3 7.9 11.8 
MC11 2 20 10 14.4 
MC12 2 4 10 14.5 
MC13 6 5 8.1 12.3 
MC14 3 4 7.8 11.9 
MC15 6 8 8 12.2 
MC16 3 2 7.9 11.9 
MC 17 4 7 6.9 10.5 
MC20 3 9 7.9 11.9 
MC23 5 10 7.9 12.2 
MC29 4.9 8 6.8 10.5 
MC38 6 10 8 12.2 
MC39 6 11 8 12.2 
MC24 3.8 6 7.8 10.5 
MC25 3 9 7.8 11.8 
MC26 4 10 7 10.7 
MC28 5 10 7.9 12 
MC31 2 7 9.7 14.3 
MC 32 5 6 7.8 12 
MC35 4 6 6.8 10.5 
MC36 6 8 8 12.2 
MC37 2 7 9.7 14.3 
MC40 4 3 6.8 10.5 
MC43 4 22 7.2 10.7 
ZW 01 2 12 9.9 14.5 
Zw 02 2 10 9.8 14.4 
ZW 03 6 9 8.1 12.3 
ZW 04 6 8 8.4 12.2 
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Sample 
no  
Age Measured BPb 
(µg/dL) 
BPb at 31% 
bioavailability for food 
lead (µg/dL) 
BPb at 50% bioavailability 
for food lead (µg/dL) 
ZW07 5 7 8.4 12.4 
ZW09 2 8 9.8 14.4 
ZW10 5 4 8.6 12.8 
ZW12 3 12 7.9 12 
ZW13 2 8 9.7 14.3 
ZW14 5 5 7.9 12 
ZW 16 2 4 10 14.6 
ZW17 2 7 9.8 14.3 
ZW 18 4 4 6.9 10.6 
ZW19 5 5 7.9 12 
ZW20 2 6 9.7 14.4 
ZW22 4 4 6.9 10.6 
ZW23 6 6 6.9 12.2 
ZW24 6 5 8 12.3 
ZW26 1.8 7 8 15.6 
ZW28 6 4 8 12.3 
ZW30 6 6 8.6 12.7 
ZW 31 3 5 7.9 11.9 
ND01 6 3 8 12.2 
ND02 2 4 9.7 14.3 
ND08 6 5 8 12.2 
ND09 2 6 9.7 14.4 
ND13 3 5 7.9 11.9 
ND14 3 4 8 12 
ND16 5 4 7.8 12 
ND18 5 4 7.9 12 
ND21 3 8 7.9 11.9 
ND22 2 6 9.8 14.4 
ND23 2 5 9.7 14.4 
ND24 5 5 8 12.1 
ND26 2 8 9.8 14.4 
ND30 2 8 9.8 14.4 
ND31 6 7 8.1 12.3 
ND32 5 5 7.9 12 
ND33 6 3 8.1 12.3 
LM03 3 6 8.5 12.3 
 178 
 
Sample 
no  
Age Measured BPb 
(µg/dL) 
BPb at 31% 
bioavailability for food 
lead (µg/dL) 
BPb at 50% bioavailability 
for food lead (µg/dL) 
LM04 3 4 7.9 11.9 
LM05 4 3 6.9 10.5 
LM06 6 6 8.2 12.5 
LM08 3 5 7.9 11.9 
BN4 1.7 10 10.6 15.5 
BN12 2 6 9.7 14.3 
BN13 2.3 4 9.7 14.3 
BN14 4 6 6.8 10.5 
BN16 3 7 7.9 11.9 
BN17 2 2 9.7 14.3 
BN18 6 7 7.8 12.2 
BN19 2.4 7 9.7 14.4 
CH 01 6 3 8 12.2 
CH02 2 5 9.8 14.4 
CH03 3 9 8.1 12.1 
CH05 6 5 8 12.2 
CH07 6 6 8 12.4 
CH08 6 7 8 12.2 
CH09 6 5 8 12.2 
CH11 4 8 6.8 10.5 
CH12 6 6 8 12.2 
CH13 3.9 10 7.9 11.9 
CH14 5 4 7.9 12 
CH15 5 7 7.9 12 
CH16 3 7 7.8 11.8 
CH20 6 12 8.1 12.3 
CH22 2 4 9.7 14.4 
CH25 6 7 8 12.2 
CH26 6 8 8.1 12.3 
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Table 19:  Estimation of contribution of lead from food to measured BPb 
Sample 
no 
Measured BPb 
(µg/dL) 
BPb using 
50 % 
bioavailabili
ty 
% 
contribution 
to BPb for 
50% 
bioavailabili
ty 
BPb using 
31 % 
bioavailabili
ty 
% 
contribution 
to measured 
BPb for 31% 
bioavailabili
ty 
50% 
contribution/31
% contribution 
MC1 2 12.2 610 8.2 410 1.49 
MC2 2 12.2 610 8.2 410 1.49 
MC3 3 11.8 393 8 266 1.48 
MC5 10 10.5 105 7 70 1.50 
MC6 18 10.5 58 7 38 1.50 
MC7 3 12.4 413 8.7 290 1.43 
MC8 3 11.8 393 8 266 1.48 
MC11 20 14.2 71 9.9 49 1.43 
MC12 4 14.2 355 9.9 247 1.43 
MC13 5 12.2 244 8.2 164 1.49 
MC14 4 11.8 295 8 200 1.48 
MC15 8 12.2 152.5 8.2 102 1.49 
MC16 2 11.8 590 8 400 1.48 
MC 17 7 10.5 150 7 100 1.50 
MC20 9 11.8 131 8 88 1.48 
MC23 10 11.9 119 8 80 1.49 
MC29 8 10.5 131 7 87 1.50 
MC38 10 12.2 122 8.2 82 1.49 
MC39 11 12.2 110 8.2 74 1.49 
MC24 6 11.8 197 8 133 1.48 
MC25 9 11.8 131 8 88 1.48 
MC26 10 10.5 105 7 70 1.50 
MC28 10 11.9 119 8 80 1.49 
MC31 7 14.2 202 9.9 141 1.43 
MC 32 6 11.9 198 8 133 1.49 
MC35 6 10.5 175 7 116 1.50 
MC36 8 12.2 152. 8.2 102 1.49 
MC37 7 14.2 202 9.9 141 1.49 
MC40 3 11.8 393 7 233 1.69 
MC43 22 11.8 53 7 31 1.69 
ZW 01 12 14.2 118 9.9 82 1.43 
ZW 02 10 14.2 142 9.9 99 1.43 
ZW 03 9 12.2 135 8.2 91 1.49 
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Sample 
no 
Measured BPb 
(µg/dL) 
BPb using 
50 % 
bioavailabili
ty 
% 
contribution 
to BPb for 
50% 
bioavailabili
ty 
BPb using 
31 % 
bioavailabili
ty 
% 
contribution 
to measured 
BPb for 31% 
bioavailabili
ty 
50% 
contribution/31
% contribution 
ZW 04 8 12.2 152 8.2 102 1.49 
ZW07 7 11.9 170 8 114 1.49 
ZW09 8 14.2 177 9.9 123 1.43 
ZW10 4 11.9 297 8 200 1.49 
ZW12 12 11.8 9 8 66 1.48 
ZW13 8 14.2 177 9.9 123 1.44 
ZW14 5 11.9 238 8 160 1.49 
ZW 16 4 11.4 285 7.9 197.5 1.44 
ZW17 7 14.2 202 9.9 141 1.43 
ZW 18 4 7.5 187.5 5.0 125 1.50 
ZW19 5 11.9 238 8 160 1.49 
ZW20 6 14.2 236 9.9 165 1.43 
ZW22 4 10.5 262 7 175 1.50 
ZW23 6 12.2 203 8.2 136 1.49 
ZW24 5 12.2 244 8.2 164 1.49 
ZW26 7 12.4 177 8.7 124 1.43 
ZW28 4 14.2 355 8.2 205 1.73 
ZW30 6 14.2 236 8.2 136 1.73 
ZW 31 5 11.8 236 8 160 1.48 
ND01 3 12.2 406 8.2 273 1.49 
ND02 4 14.2 355 9.9 247 1.43 
ND08 5 12.2 244 8.2 164 1.49 
ND09 6 14.2 236 9.9 165 1.43 
ND13 5 11.8 236 8 160 1.48 
ND14 4 11.8 295 8 200 1.48 
ND16 4 11.9 297 8 200 1.49 
ND18 4 11.9 297 8 200 1.49 
ND21 8 11.8 147 8 100 1.48 
ND22 6 14.2 236 9.9 165 1.43 
ND23 5 14.2 284 9.9 198 1.43 
ND24 5 11.9 238 8 160 1.49 
ND26 8 14.2 177 9.9 123 1.43 
ND30 8 14.2 177 9.9 123 1.43 
ND31 7 12.2 174 8.2 117 1.49 
ND32 5 11.9 238 8 160 1.49 
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Sample 
no 
Measured BPb 
(µg/dL) 
BPb using 
50 % 
bioavailabili
ty 
% 
contribution 
to BPb for 
50% 
bioavailabili
ty 
BPb using 
31 % 
bioavailabili
ty 
% 
contribution 
to measured 
BPb for 31% 
bioavailabili
ty 
50% 
contribution/31
% contribution 
ND33 3 12.2 406 8.2 273 1.49 
LM03 6 11.8 196 8 133 1.48 
LM04 4 11.8 295 8 200 1.48 
LM05 3 10.5 350 7 233 1.50 
LM06 6 12.2 203 8.2 136 1.49 
LM08 5 11.8 236 8 160 1.48 
BN4 10 12.4 124 8.7 87 1.43 
BN12 6 14.2 236 9.9 165 1.43 
BN13 4 14.2 355 9.9 247 1.43 
BN14 6 10.5 175 7 116 1.50 
BN16 7 11.8 168 8 114 1.48 
BN17 2 14.2 710 9.9 495 1.43 
BN18 7 12.2 174 8.2 117 1.49 
BN19 7 14.2 202 9.9 141 1.43 
CH 01 3 12.2 406 8.2 273 1.49 
CH02 5 14.2 284 9.9 198 1.43 
CH03 9 11.8 131 8 88 1.48 
CH05 5 12.2 244 8.2 164 1.49 
CH07 6 12.2 203 8.2 136 1.49 
CH08 7 12.2 174 8.2 117 1.49 
CH09 5 12.2 244 8.2 164 1.49 
CH11 8 10.5 131 7 87 1.50 
CH12 6 12.2 203 8.2 136 1.49 
CH13 10 11.8 118 8 80 1.48 
CH14 4 11.9 297 8 200 1.49 
CH15 7 11.9 170 8 114 1.49 
CH16 7 11.8 168 8 114 1.48 
CH20 12 12.2 101 8 66 1.53 
CH22 4 14.2 355 9.9 247 1.43 
CH25 7 12.2 174 8.2 117 1.49 
CH26 8 12.2 152 8.2 102 1.49 
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Table 20:  Estimation of contribution of lead from soil to measured BPb 
Sample 
no  
Age Measured 
BPb 
(µg/dL) 
Predicted BPb for 
soil (µg/dL) 
% contribution of soil lead to measured 
BPb 
     
MC3 3 3 0.1 3.33 
MC5 4 10 2.3 23.0 
MC6 4 18 2.3 12.8 
MC7 1 3 0.2 6.67 
MC8 3 3 0.1 3.33 
MC11 2 20 0.2 1.00 
MC12 2 4 0.5 12.5 
MC13 6 5 0.2 4.00 
MC14 3 4 0.1 2.50 
MC16 3 2 0.2 10.0 
MC 17 4 7 0.1 1.43 
MC20 3 9 0.1 1.11 
MC23 5 10 0.1 1.00 
MC29 4 8 0.1 1.25 
MC39 6 11 0.1 0.909 
MC24 3 6 0.1 1.67 
MC25 3 9 0.1 1.11 
MC26 4 10 0.3 3.00 
MC28 5 10 0.1 1.00 
MC31 2 7 0.1 1.43 
MC 32 5 6 0.1 1.67 
MC36 6 8 0.1 1.25 
MC43 4 22 0.4 1.82 
ZW 01 2 12 0.3 2.50 
Zw 02 2 10 0.3 3.00 
ZW 03 6 9 0.1 1.11 
ZW 04 6 8 0.1 1.25 
ZW07 5 7 0.7 10.0 
ZW09 2 8 0.2 2.50 
ZW10 5 4 1.1 27.5 
ZW12 3 12 0.3 2.50 
ZW13 2 8 0.1 1.25 
ZW14 5 5 0.1 2.00 
ZW 16 2 4 0.5 12.5 
ZW17 2 7 0.2 2.86 
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Sample 
no  
Age Measured 
BPb 
(µg/dL) 
Predicted BPb for 
soil (µg/dL) 
% contribution of soil lead to measured 
BPb 
ZW 18 4 4 0.1 2.50 
ZW19 5 5 0.1 2.00 
ZW20 2 6 0.2 3.33 
ZW22 4 4 0.1 2.50 
ZW23 6 6 0.1 1.67 
ZW24 6 5 0.1 2.00 
ZW26 1 7 0.2 2.86 
ZW28 6 4 0.1 2.50 
ZW30 6 6 0.8 13.3 
ZW 31 3 5 0.2 4.00 
ND01 6 3 0.1 3.33 
ND02 2 4 0.1 2.50 
ND08 6 5 0.1 2.00 
ND09 2 6 0.1 1.67 
ND13 3 5 0.1 2.00 
ND14 3 4 0.3 7.50 
ND18 5 4 0.1 2.50 
ND21 3 8 0.1 1.25 
ND22 2 6 0.2 3.33 
ND23 2 5 0.1 2.00 
ND24 5 5 0.2 4.00 
ND26 2 8 0.2 2.50 
ND30 2 8 0.3 3.75 
ND31 6 7 0.1 1.43 
ND32 5 5 0.2 4.00 
ND33 6 3 0.2 6.67 
LM03 3 6 0.8 13.3 
LM04 3 4 0.1 2.50 
LM05 4 3 0.1 3.33 
LM06 6 6 0.4 6.67 
LM08 3 5 0.2 4.00 
BN4 1 10 0.1 1.00 
BN16 3 7 0.2 2.86 
BN17 2 2 0.1 5.00 
BN19 2 7 0.2 2.86 
CH02 2 5 0.3 6.00 
CH03 3 9 0.5 5.56 
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Sample 
no  
Age Measured 
BPb 
(µg/dL) 
Predicted BPb for 
soil (µg/dL) 
% contribution of soil lead to measured 
BPb 
CH05 6 5 0.1 2.00 
CH09 6 5 0.1 2.00 
CH13 3 10 0.3 3.00 
CH14 5 4 0.1 2.50 
CH15 5 7 0.1 1.42 
CH16 3 7 0.1 1.43 
CH20 6 12 0.2 1.67 
CH22 2 4 0.1 2.50 
CH26 6 8 0.1 1.25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 185 
 
7.3 Appendix 3 
 
 
Ethics Approval from Malawi 
 
 
Ethics approve from University of Witwatersrand 
 186 
 
 
